Brunfelsia Hopeana - Pharmacologic Screening: Isolation And Characterization Of Hopeanine by Iyer, Radhakrishnan Parameswaran
University of the Pacific 
Scholarly Commons 
University of the Pacific Theses and 
Dissertations Graduate School 
1978 
Brunfelsia Hopeana - Pharmacologic Screening: Isolation And 
Characterization Of Hopeanine 
Radhakrishnan Parameswaran Iyer 
University of the Pacific 
Follow this and additional works at: https://scholarlycommons.pacific.edu/uop_etds 
 Part of the Pharmacy and Pharmaceutical Sciences Commons 
Recommended Citation 
Iyer, Radhakrishnan Parameswaran. (1978). Brunfelsia Hopeana - Pharmacologic Screening: Isolation And 
Characterization Of Hopeanine. University of the Pacific, Dissertation. 
https://scholarlycommons.pacific.edu/uop_etds/3318 
This Dissertation is brought to you for free and open access by the Graduate School at Scholarly Commons. It has 
been accepted for inclusion in University of the Pacific Theses and Dissertations by an authorized administrator of 
Scholarly Commons. For more information, please contact mgibney@pacific.edu. 
J3HUNFELSIA HOPEP.NA - PH.:"\Rf,!ACOLOGIC SCREENING: ISOLATION 
A~~ CHARAC~EniZATION OF HOPEANINE 
A Dissertation 
Presented to 
the Faculty of the Graduate School 
UnivBrsity of the Pacific 
In Partial Fulfillment 
of the RP~uirements for the Degree 
Doctor of Philosophy 
by 
Radhakrish.nan Parameswaran Iyer 
May, 1978 
.I 
BRtlNFELSIA HOPEANA - PHARMACOLOGIC SCREENING; ISOLATION 
AND CIL'\RAC'I':CRIZA'fiON OF HOPEANINE 
Abstract of the Di~sertation 
The genus 3ru~f~l~ia (Pam. SolanncBae) com~rises 
some ilQ species of shrubs native to South A!'rwrica .and West 
Ind.ies. Brunfelsia hopE:-:ana ( com.r.ron n:nn0.: ~.1::ma.ca J~oot) 
and related species are recognized in folk medicj~ ~ in 
South America as being useful as diuretic. antirb: <<matic, 
antisyphilitic agen~s and as narcotic hal!ucinogens. In 
view of the interesting folhloric uses and a pauci~y of 
chemical and pharmacological investi~ation of B. hopeana, 
a systematic phytochemical and pharmacological investi-
gation on B. bopeana was undertaken in our laboratory. 
Hippocratic screening of the whole root pov.·de·r 
.and extracts of n. _ _!!._~e~na administered i nt r.apcri toni ally 
to rats, indicated ~hat the whole root had CNS depressant 
activity and that the chloroform extract which contained 
the basic or 'alkaloidal' fraction concentrates this ac-
tivity. The chloroform extract at an ora.l dose level of 
100 mg/Kg, was ~qually effective (w/w) ns rhenylbutazone 
in reducing carrageenin-induced pedal edema in rats. 
In addition, the extTact als"J exhihitcd significant 
in vitro selective toxicity against SV 3T3 cells at a dose 
1evel of 2000 ~g/ml. Based en tbcs~ results, detailed 
studies on the isolation and characterization of the con-
stituents of tbe chloroform ·extract: were cnrried out. 
t~ large-scale extraction of the plar.t mater.ia1 
provided significant amounts of the chToro.forrr. extract 
for f11rAther study. Isolation of the constituents of the 
extract, was carried out using Cblu~n- and Preparative 
T!lin-Laye::~ Chrom:-.l.to.~raphy. Three a l:ka.l ot ds desi gr. a ted 
as Alka.loid I. Alkaioid .II, and Alk:~loid III and in ad-
dition a prevto;.:s1y isolated coumarin cor.ipo!.!r.d, ~copoletin, 
were obtained from the chloroform cxtr~ct. The major 
'alkaloidal' component was Alkaloid III. The struc.ture 
of th.ts compound w:1s P.1ucidatcd wj th thP hcdfJ of UV: IR, 
PMH ~ C-13 NMR and Low- and High H.c~:o lu t ion ~lass Spcetros<;opy. 
ii 
iii 
Based on these data, the following structure was assigned 
to Alkaloid III. 
A surv·ey of the literature to d::te showed that the 
structure of Alkaloid III was unique and new ; being reported 
for the first time. The name 'Hopeanine' w;:~s therefore 
given to this compound. Alkaloid I and Alkaloid II were 
obtained in small amounts and bencG only partial char~cter­
ization of these two constituents could be achieved. 
·'t· 
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INTRODUCTION 
THE GENUS BRUNFELSIA 
Plants of the genus Brunfelsia belong to the family 
Solanaceae. This family comprises 85 genera and about 1800 
species of plants (1). The family is distributed primar-
ily in tropical South America where there are reportedly 
38 endemic genera. The Solanaceae are a family of consider-
able economic importance and include food plants such as 
the potato, egg plant ~ tomato and strawberry tomato. The 
tobacco plant (fumitory) and such drug plants as henbane, 
belladonna, atr~pa and strrunonium also belong to this 
family. In addition, ornamentals from many g.enera such 
as Petunia, Salpiglossis, Schizanthus, ~yciu~, Solanum, 
Streptosolen, Ce strum,. Datura, Solandra, Browallia, 
Nierembergia also belong to this family (2). 
The genus Brunfelsia was named after Otto Drunfels, 
a botanist of Metz (16th century) (3). The genus com-
prises approximately 40 species of shrubs native to South 
America and the West Indies, and to some extent distrib-
uted in the Malayan Peninsula (4). Plants of this genus 
have a rich folkloric medical history and have attracted 
attention in recent years both from ethnobotanic and 
chemotaxonomic points of view (5). 
1 
Folkloric Medic~nal History of the Genus Brunfelsia 
Chiric-Caspi and Chiric Sanango (Brunfelsia) are 
the most common names for the several species of the 
genus Brunfelsin that appear to have been important 
hallucinogens among certain South American Indian tribes 
( 5 )_. The use of the name "borrachero .-" which means 
''intoxicator," indicates that the natives of Colombia, 
Ecuador and Peru recognize the shrub's narcotic proper-
ties an-d the special care taken in it.s cultivation seems 
to suggest a religious or ma~ic place in tribal rites. 
Recent evidence (5) has pointed to the us-e of several 
species of Brunfelsia either as the source of an 
hallucinogenic drink-_, as among the Kacbinaua ot Brazil, 
or as an additive to other hallucinogenic drinks, as 
2 
among the Jivaro and Kofan Indians of Ecuador. The species 
thus employed are B. grandiflora and B. chiricaspi. All 
species, however, enter into folk medicine, being used 
especially to reduce fevers and as antirheumatic agents. 
B. uniflora and B. hopeana have been included in the 
Brazilian Pharmacopoeia (5). 
Annotations on labels of several herbarium speci-
mens collected in eastern Colombia and Peru indicate that 
these species of Brunfelsia cultivated in Indian dooryards 
are considered to be both narcotic and medicinal (6). 
Other collections from Bolivia, Brazil, Colombia, Peru, 
Ecuador also indicate a broad spectrum of therapeutic uses, 
ranging from "yellow fever" to "snake bite" ( 6). The 
r 
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3 
infusion of the scraped bark of Brunfels·ia produces a 
sensation of chill and coldness (6). The lowland Quichwas 
on the Rio Napa of Ecuador utilize the plant medicinally 
as a remedy for rheumatism and it is reported that ''they 
take it if they have a burning sensation in the lower part 
of their back. They place their hands in the area of the 
kidneys. Upon making a drink from the leaves in hot water, 
they become excessively chilled after drinking." A col-
lection of Brunfelsia maritima from hlocoa in Southern 
Colombia, indicates that the shrub, reportedly toxic, is 
likewise called "borrachera" in this locality (7). 
BRUNSFELSIA HOPEANA 
A survey of the literature indicates that t -he 
species Brunsfelsia hopeana (Benth) to be most often used 
in native medicine under the name of "manaca." The species 
was also named Franciscea hopeana by Pohl for Emperor 
Franz II of Austria during whose reign he traveled through 
Brazil ( 3). Brunfelsia hopeana f i .rst appeared in The 
Dispensatory of the United States (USD) in 1892 (8a) under 
the name Manaca. It was continuously listed in USD until 
1960. In addition, in 1926 only, two preparations, under 
the titles "Fluid Extractum Manacae, N. F-." and "E.lixi-r 
Manaca Composi tum, N. F. , " were 1 ist ed. in the USD ( 8b). 
National Formulary (N. F. )V lists the dried root of manaca 
(9a), Elixir Manacae Compositum (9b) and Fluid Extractum 
Manaca& (9cJ. Franciscea uniflora Pohl and Brunfclsia 
r 
i 
! 
I 
I 
I 
4 
uniflora appear to be the scientific synonyms for this 
plant (3, 8b). B. hopeana is recognized by various other 
co~rion names. According to Mortius (1829), in Brazil, it 
is known as "manacan" and as "geratacaca" and "camgamba." 
In Paraguay it is called "mercuric vegetal" (10). Other 
names include: "gerataca" or "jerataca" (which in the 
language of the Indians signifies a remedy again~t snake 
bite), "urnbura-pauma" (tree of cures), bloom of the Lent, 
Christmas bloom and Santa Maria (11). According to 
Theodore Peckolt (12), the more frequently used uame 
"manaca," originates from an ancient tribe, which named 
the shrub after a very l .ovely maiden called Manaja. Other 
names include, Paraguay jasmine and good night. 
Folkloric Medicinal History of Brunfelsia hopeana 
B. hopeana was employed by the natives of South 
America, before the arrival of Portuguese, as a remedy 
against arrow poison (11). In 1867, Edmon, who lived on 
the Amazon, reported that the· flowe.rs of manaca or fran-
ciscea were applied to indolent ulcers and that a decoction 
of the root was regarded as a sovereign remedy for 
rheumatism. It was also believed to be useful in small 
doses as an emetic, cathartic, diaphoretic and diuretic 
and in large doses as an. acrid poison (10). "It was em-
ployed not only in rheumatism, but also in syphilis and 
other diseases in which mercury is indicated" (13). Other 
sources ( 10) indicate that the root acts as an ir·ri tant 
of the stomach and bowels, causing vomiting, purging 
r 
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and abortion in pregnancy and even death. 
A thesis on the toxic plants of Brazil (14) reports 
that the roots of manaca were employed by the Indians to 
produce strong delirium resembling :persistent madness. 
Some tribes in the interior Amazon use this extract as an 
arrow poison (11). Egon (11) claims the successful use 
of manaca in cases of rheumatism and as a profuse diaphoretic 
agent and pain reliever. A decoction of the root has been 
employed as an irrigant for eczema and syphilitic tumors. 
It is considered a most valuable alternative in rheumatic 
arthritis (15). The leaves- of the plant were used by 
primitive people as an antidote for snakebites (11). 
B. hopeana is one of the fascinating drug plants 
and has t ·he potential for being added to t _he list of 
au.thentic hallucinogenic plants. The evidence for the 
narcotic use of the plant is real, but not corroborated 
by a good body of evidence and observation (7, 16). The 
Kofan Indians of Amazonian Colombia and Ecuador, as· well 
~ 
as the Jivaro of Ecuador, occasionally add the leaves and 
bark of cultivated B. hopeana to their "yaje" or "natema" 
drink which is prepared basically from Ba nister-iopsis. 
This use of Brunfelsia and its narcotic properties is well 
known in the Colombian Putumayo, where the shrub is called 
"borrachero" ( ' 1 intoxicant") amongst the non-Indian popu-
lation (17. 18). Table 1 gives the folkloric medicinal uses 
of B. hopeana. 
I 
I 
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Tabl-e I: Folkloric ~tedicinal Uses of nrunfelsin. hopeana 
Plant Parts 
(Preparation) 
Root Infusion 
Root Power 
Root Power 
Leaves 
Root Decoction 
Root 
Alleged use. 
Diuretic, anti-
rheumatic; anti-
syphilitic 
Yellow fever, snake 
bite; febrifuge, 
antirheumatic 
Purgative 
Arrow poison 
To induce abortion 
Emetic, cathartic; 
diuretic, diaphor~tic; 
antisyphilitic; skin 
and mucous membrane 
infections 
Areas of use 
( Refe_rence) 
Brazi 1 ( 7, 17) 
Bolivia, Brazil, 
Colombia, Ecuador, 
and Peru (6, 7) 
Brazil (11) 
Brazil (11) 
Africa (11) 
Amazon (11) 
.. 
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A Literature Survey of Phytochemistry 
and Pharmacolog-y of B. hopeana 
7 
Pharmacology. B. hopeana has attracted the atten-
tion of pharmacologists from very early times. As early 
as 1882, Brewer (19) investigated the pharmacological ac-
tions o:f B. hopeana. According to Brewer, one or two 
fluidrachms or 4-8 g of the fluid extract of the roots .of 
B. hopeana in man, produced a restlessness which could be 
allayed by walking and which was followed by a peculiar 
sense of fatigue. From these observations and from experi_-
men~s on frogs and kittens, Brewer concluded that the 
fluid extract a) acted primarily on the spinal cord result-
ing in the stimulation of motor centers, b) stimulated 
salivary and gastric secretions, c) stimulated the intes-
tine, liver and the kidneys, and d) depressed the ,cardiac 
reflex center" and "'respiratory reflex centBr." The total 
duration of action was three and a h~lf hours. 
The most intensive phytochemical and pharmacological 
investigation of B. hopeana root to date was carried out by 
Brandl (20). Brandl, inves.tigating the pharmacological 
actions of B. hopeana on various laboratory animals, re-
ported that the plant possessed tetanus toxin-like activity. 
lie stated that "the primary symptom of intoxication was 
severe tremors in the head which lasted for a short time, 
followed by more rapid contraction of some facial muscles. 
Laboratory animals got restless, passed urine and feces, 
showed int~nse salivation and strong lacrimation." At 
i 
1 
.I 
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lethal doses, there was generalized muscle contraction, r -e-
sembling ,epilepsy .. " During this period "there was periodic 
cessation of respiration about five or six times, ulti-
mately resulting in respiratory failure, heart continuing 
to beat in regular rhythm.'' M.artin Costa (21) observed 
that oral administration of a dilute alcoholic extract of 
man.aca root and intrav·enous injection of .aqu·eous extract, 
produced eff-ects quite similar to that of digitalis, "in-
creasing the strength, but decreasing the number of contrac-
tions of the heart, with a concomitant increase in arterial 
tension .. " 
According to Capanema (11), drinking the tea or 
infusion of B. hopeana produced excessive salivation and 
ulceration of buccal mucosa. He also reported of a man 
who took a cup of the root decoction which produced copious 
sweating , vertigo, general loss of sensitivity, incomplete 
paralysis of facial muscles, totally disturbed vision, 
trouble in walking, and rheumatic pains. An intense pain 
was also felt in the knee joints. After several hours, 
the symptoms disappeared and there was a reduction in the 
swelling of the knee joints. Freire de Cisneiros (22) re-
ported that B. hopeana had a "characteristic" action on 
the hea·rt. 
Phytochemistry. B. hopeana has also attracted the 
attention of phytochemists from very early times. The 
presence of alkaloids and the isolation of basic materials 
have be-en reported in older literature •. but the characterization 
9 
of the components has been insufficient. It is also quite 
probable that there bas been some confusion among tbe various 
plants which are natively known as "manaca" and this has 
contributed to the uncertainty as to the chemical composi-
tion of manaca (10, 23, 24, 25). 
In 1884, Lenardson (26) analyzed manaca and from 
the microscopic structure, he believed that manttca belonged 
to the Apocyanaceae family. Besides fat, resin, ash, starch 
and. various other compounds, Lenardson report-ed the isola-
tion of an alkaloid, "manacine," and a fluorescent com-
pound. "Manacine" was assigned a molecular composition 
of c1_5H22N4o5 . The fluorescent compound was thought to be 
gelseminic acid. i.e. the coumarin derivative _, scopolet i.n. 
The alkaloid "manacine" was described by Lenardson as below: 
"Manacine is a weak base, has slight bitter 
taste, di~lyzes readily, but has not been obtained 
in crystals. It dissolv~s readily ln water, 
alcohol, and methyl alcohol, is insoluble or nearly 
so in other liquids, is easily decomposed in solu-
tion with separation of a brown Tesin, the hydro-
chloric acid solution being mor~ stable than others, 
and is precipitated from its more or less concen-
trated solution by the reagents for al.kaloids, but 
not by alkali8s. The precipitate by phospho-
molybdic acid dissolves in potash with a blue 
color. Characteristic color re~ctions were not 
observed." 
~A few years later, Lascelle Scott (27) reported 
the pres-ence of an alkaloid, "francisceine," but was unable 
to assign a formula to it. Pammel (28) and Wehmer (29) 
remarked on the use of B. hopeana as an arrow poison and 
stated that it contained two alkaloids, "mandragorine" 
and "manacine_." 
i 
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The most intensive phytochemical and pharmacological 
investigation of ma·naca was carried out by Brandl ( 20). He 
isolated two alkaloids "manacine" (to which he assigned 
the formula c22H32N2o10) and "ma·naceine" (C15H21N2o9 ). He 
further remarked that in aqueous solution, manacine seemed 
to decompose to manaceine and a fluorescent compound which 
he believed might be identical with esculetin. Although 
Brandl assigned a molecular formula to certain of his 
materials, it is apparent that none were isolated in pure 
crystalline form. 
Later Peckvlt (12), claimed to have i3olated from 
manaca, an amorphous substance of pale yellow color called 
"brunfelsine." 
Various other sources (6, 18) have ·p!:'edicted the 
presence of atropine-like alkaloids in manaca, based on 
its pharmacological properties and taxonomic relationships 
to solanaceous plants such as Atropn., Hyoscyamus and 
Datura. 
It is thus apparent that so far only preliminary 
chemical investigations of B. hopeana have been carried out. 
While the o·lder literature mentions the isolation of alka-
loidal eomponents such as "francisceine," "manacine" and 
"brunfelsine," none of thes-e seem to have been isola ted in 
pure form and satisfactorily characterized (17). In a more 
recent report on the investigation of B. hope ana, B. pauciflora 
and B. brasiliensis, the presence of alkaloids was not men-
tioned, but the isolation of scopolctin, wus again reported 
( 30 ). 
11 
SCOPE OF Tiill PRESENT ~~~ESTIGATIONS 
The lack of knowledge concerning the chemical con-
stituents of B. hopeana, coupled with reports of interest-
ing pharmacological activity and folkloric use, suggested 
that a detailed phytochemical and pharmacological investi-
gat ion of this plant would p_rove to be fruitful. 
So f.ar only one constituent of this plant--a coumarin 
derivative, scopoletin--has been satisfactorily character-
ized. Although the presence of alkaloidal constituents have 
been reported, these have not been isolated in sati.sfac-
tory pure crystalline form. Hence the molecular formulas 
and physical constants assigned to these isolated fractions 
may be questioned as to their validity. 
The investigation reported here is divided into 
the following phases. 
a) Preliminary phytochemical screening 
b) Development of a suitable extraction pro-
cedure and preparation of various extracts 
c) Pharmacologic screening of the extracts 
i) Hippocratic screening 
ii) Cytotoxic activity 
d) Specific pharmacological screening of the 
active fraction from step (c), based on 
folkloric use and the observed results 
of hippocratic screening 
e) Large scale extraction to obtain the active 
fraction(s) for phytochemical investiGation. 
I 
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f) Isolation of the constituents of the ac-
tive fraction by chromatographic methods. 
g) Structure determination of the constituents 
by spectroscopic techniques. 
h) Pharmacological screening of the isolated 
chemically pure constituents. 
EXPERIMENTAL 
PLANT UATERIAL 
Brunfelsia bopeana root coarse powder1 and whole 
root 2 were reduced to 40 mesh powder in a Wiley Mill. 
Herbarium specimens of all were prepared and have been 
kept for reference in the Pharmacognosy Laboratory, School 
of Pharmacy, University of the Pacific, Stockton. This 40 
mesh _powder was used in all the extraction procedures. 
PRELIMINARY PHYTOCHElJICAL SCREENING 
One hundred g powder was continuously P"~rcolated 
\vith about 1200 ml of cold metha-nol (Analytical Reagent 
Grade; . all solvents used in those investigations were 
Analytical Reagent grade). The percolate was concentrated 
to 50 ml. The extract was designated as extract B and 
tested for presence of alkaloids according to the follow-
ing method ( 31): 
1Lot #1404, BJM 001, received 7JS/6S, S. B. Penick 
& Co., New York, NY. 
2Lot # Sec. 9, # 53i, received 10/3/75, Wide World 
of He-rbs Ltd. , New York, NY. 
13 
a) Preliminary alkaloid test: To 2.0 ml of 
extra~t B, 2.0 ml of 2N HCl was added, fil-
tered with the aid of Celite. The filtrate 
14 
was divided into two equal parts in separate 
test tubes. A few drops of Mayer's reagent 
was added to one of the test tubes. A definite 
turbidity was observed. This gave prelimin-
ary evidence that alkaloids were present in 
the plant. 
b) Confirmatory alkaloid test: To about 20 ml 
of the original extract B, 5.0 ml of 2N H~l 
was added, slightly warmed with stirring, 
and filtered with the aid of Celite. The fil-
trate was rendered alkaline with sufficient 
NH40H. The alkaline solution was transferred 
to a separatory funnel and extracted with two 
20-ml portions of chloroform. These two chloro-
form extracts were combined and evaporated to 
dryness under vacuum (< 45°). A small portion 
of the dry extract was treated by 2.0 ml of 2N 
HCl, stirred and filtered. The filtrate was 
divided into two equal parts in separate test 
tubes. A few drops of Mayer's reagent was 
added to one of the test tubes. A definite 
turbidity was observed. A few drops of Wagner's 
reagent was added to the other test tube. Again 
a definite turbidity was observed. This con.-
firmed the prcsenc·e of alkaloids. 
15 
Development of Extraction Procedure 
Coarse root powder (20-40 mesh) was subjected to 
the following series of extraetion procedures: 
Cold Extraction: Three percolators were packed 
Hot Extraction: 
with 100 g each of the root pow-
der and subjected to: 
a) Percolation with methanol 
b) Percolation with methanol:water 
(50:50) 
c) Percolation with water 
The hot extrac tions were ca-rried 
out in Soxhl et extractors (3la): 
a) Extraction with methanol 
b) Extraction with methanol:water 
(50:50) 
In all the above cases, percolation and extraction were 
continued to exhaustion i.e. until the extract showed a 
negative test with Mayer's reagent. 
Thin-Layer Chromatography (TLC) 
All the extracts were concentrated to a small volume 
and the res~due subjected to TLC using the following system: 
Plates: Silica Gel 60 (0.25 mm), without 
fluorescent indicator 
Solvent: Butanol:acetic acid:water (4:1:5) 
The plates were developed for a length of 1£ em~ dried at 
100° and sprayed with Dragcndorff's reagent (Munier and 
. 
I 
I 
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Machcboeuf modified) (32). The hot and cold aqueous ex-
tracts did not show any Dragendorff-positive spots. Both 
cold and hot methanol as well as methanol : water (50:50) 
extracts showed Dragendorff-positive spots, indicating 
the presence of alkaloids, and were further treated as 
below·: 
The extracts were diluted with \\:ater, a.cidified 
with 2N HCl and filtered with the aid of Celite. The fil-
trate was basified withNH4 0H and extracted with c·hloroform. 
The chloroform layer was dried over anhydrous sodium sul- · 
fate and then evaporated to dryness. The residue was taken 
up in minimum amount of chloroform and TLC performed in 
the same system as above. The ·Dragendorff-positive spots 
observed bef·ore were seen again. 
PHAPJ.!ACOLOG !CAL SCREENING 
Hippocratic Screening 
The hippocratic screening procedure in unanesthetized 
rats, as developed by Malone and Robichaud (33), was used 
throughout this study. The main purpose was to determine 
which extract should receive prime consideration in phyto-
chemical work. 
Non-fasted male albino rats (150-200 g, Sprague-
Daw~ey strain)1 were used. Food and water were allowed 
1 simonsen Laboratories, Gilroy, California. 
l 
II 
li 
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ad libitum before and two hours after intraperitoneal 
injection. 
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Test materials (whole root powder and extracts) 
were suspended in freshly prepared aqueous 0.25~ agar2 by 
trituration in a glass mortar just prior to actual admin-
ist_rat ion. 
Tbe coarse root powder 20-40 mesh of B. hopeana 
was reduced to 200-mesh powder in a Norton Grinding Mill, 
using a porcelain jar and Burundum chips3 before dos~ng 
the animals with whole root for hippocratic screening. 
Based on t .he result-s of the initial phy-tochemical 
screen, as described in the preceding pages, an extrac-
tion scheme was developed as described in the Figure 1. 
Those extracts which were subjected to hippocratic screen-
ing are asterisked. 
The test samples were administered in log-dose 
sequence as intraperi tonial inject ions \Vi t -h a constant 
dosage volume of 5 mljKg. Sterile disposable syringes of 
l-or 3-ml capacity with 25 gauge, 3/8-inch or 20 gauge l-
inch needles were employed. Details of the proc-edures 
and worksheets for recording observations over the seven-
day period were those given by Malone and Robichaud (33). 
2Agar (Lot #0140-01), Difco Laboratories, Michigan. 
3chcmical Processing Div .• formerly U.S. Stone-
ware Inc., Akron, Ohio. 
SCHEME I 
BH (IOOg, 20-40#.) 
MeOH, 1000 ml 
Per~olate 
MeOH MARC( C)* 
I 
DRY EXTRACT (B)*' 
(3.1 g) 
SCHEM£2 
MeoH· 
BH (100.1;'1) 
MeOH,IOOOml 
Percolate 
·MARC 
2N HCI 
Filter 
RESIDUE FILTRATE 
SCHEM€3 
BH (500g) 
I 
MeOH 
MeOH, 4000 ml 
Percolate 
r. Cone. 50ml 
2.2N HCI 
MARC 
3. PET ETHER (40'!.. GO•) 
(2 x t50 ml) 
AQUEOUS PET ETHER 
ETHER (2 x 150ml) 
AQUEOUS ETHER 
I. NH3, pH 10 
2.CHC13(4 x 250 ml) 
CHCI3 
I 
DRY 
EXTRACT(F)* 
{0.85g, OJ7 ~.} 
AQUEOUS 
CHCI3 
' 
I. NH3, pH 10 
2.CHCI~J3 x ZOOml) 
AQUEOUS 
' 
DRY 
EXTRACT (D)* 
DRY 
EXTRACT(E)* 
(0.9CJ) (1.9CJ) 
SCHEME 4 
BH(I5Kg) 
v 
, 
v 
DRY 
EXTRACT(.F) 
(20g) 
SCOPOL£TtN* 
(0.5~~ 
O.OQ~~~-"/o) 
Column 
Chromo tog rtJ phy 
Siiica gel 
C6H6-Me0H 
ALKALOIDS (Under 
~tiJdy) 
Fig. 1. Schemes of extractic ;·.- . ···;~t~~ powdered root of 
Erunfelsia hopeana · 
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Cytotox~c Activity 
In 1962, the Cancer Chemotherapy National Service 
Center (CCNSC) issued a number of protocols for screen-
ing chemical agents and natural products against ani.mal 
tumors and tumor cells in culture (34). The KB (Eagle) 
cell culture system is normally employed for screening 
plant extracts because it is useful as a "pre-screen" fn 
showing concentrates that also show in vivo activity (35). 
In the present investigation, the effect of the plant 
extracts on. normal and transformed cells in culture was 
studied. The index used for determination of cell growth 
was cell count. No attempt was made to determine the 
effect of the extract on protein synthesis ~ Because of 
the nonavailability of KB cells, SV 3T3 and 3T3 cells were 
used in the present investigation. Basal modified 
Eagle's medium (36) was used for growing the cells. 
Stock solutions of the extracts B and F (Fig. 1) 
with a concentration of 2000 ~gfml were prepared using 
the following procedure. Ten mg of the d.ry extract was 
dissolved in 2.2 ml of 95% ethanol . The solution was then 
diluted to 5. 0 ml with normal sali.ne to give a final con-
centration of 2000 ~g/ml. 
The extract B was studied for growth inhibitory 
property at dose levels of 0, 50, 100, 200 and 400 ~gjml. 
The following scheme was employed (0 = a petri plate) 
r 
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3T3 sv 3T3 
c a b d e c a b d e 
:Day 1 0 0 0 0 0 0 0 0 0 0 
Day 2 0 0 0 0 0 0 0 0 0 0 
Day 3 0 0 0 0 0 0 0 0 0 0 
Day 4 0 0 0 0 0 0 0 0 0 0 
Day 5 0 0 0 0 0 0 0 0 0 0 
Day 6 0 0 0 0 0 0 0 0 0 0 
a ....... 50 l!g/ml concentration of extract B 
i 
b ....... 100 vg/ml concent.ra t ion of ext.ract B j d ........ .200 .lJg/ml concentration of extract B 
e . . . . . . . 400 }.lg/ml concentration of extract B 
c . - ...... control concentration of extract B 
The stock culture of 3T3 and SV 3T3 cells were sus-
pended in 150 mls of basal modified Eagle's medium. Four 
ml of the medium were transferred to each of t .he 60 dishes. 
Three tenths of a ml of the solution was taken separately 
and the cells counted. The cells were then incubated for 
24 hours and the extract was added to the dishes a·nd incu-
bated again. 
For counting the cells, each dish was removed, 
trypsiniz-ed, and the contents transferred to a sample bottle 
and diluted to 10 ml with saline. The sample bottle was 
placed in a Coulter counter unit which estimated the number 
of cells in 100 }.ll of the solution. The total cell popu-
lation was then computed. 
I 
I 
I 
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The extract F (Fi~l) obtained was also used to study 
its _growth inhibitory property. The experiment n.l set up 
was as described above under extract B except t .ha t a single 
do.se level of 2000 llg/m·l was employed. 
Antiinflammatory Screening 
In view of the folkloric uses of Brunfelsia hopeana 
as an antirheumatic agent and based on the observed results 
of hippocratic screening, extract F was also subjected to 
antiinflammatory evaluation. Carrageenin-induced pedal 
edema in rats was used as the experimental model (.37) and 
the effect of the extract ·F in reducing inflammation was 
compared to the known antiinflammatory effect of phenyl-
butazone . 
. Approximately seven-week old, male albino, Sprague-
Dawley rats weighing between 120 and 150 g were allowed at 
least six days in our rat quarters(after shipment was re-
ceived)to allow for acclimatization before experimentation. 
Daily body weights were checked to document whether or not 
no.rmal growth patterns were present. Rat quarters consisted 
of an 8. 5 meter x 5. 2 meter room ke·pt at constant tempera-
ture (21°) and humidity and supplied with natural illum-
ination from a 3.4 meter x 0.8 meter frosted window. Cages 
were positioned to approximate uniform lighting. Artificial 
lights were kept off, -except during actual experimentation. 
All animals were offered a diet of commercially prepared 
food pellets4 and tap water ad ljbitum. All drugs were 
4Purina Rat Chow. Crude protein not less than 30%, 
crude fat not less than 4.5%, crude fiber not less than 6.0%, 
ash not less than 9%, plus vitamin and mineral supplement. 
L 
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suspended in 0.25% agar and orally administered using a 
constant 10 ml/Kg dosage volume. The extract F and phcnyl-
butazone5 suspensions in agar were each made up daily just 
prior to use. Sodium pentobarbita1 6 solution was made up 
every two days and refrigerated at 4° after use. A 1% 
solution of carrageenin7 in 0.9% salin€ was used as the 
phlogistic agent. 
A total of 30 male rats were used in the study. 
A line was drawn across the top edge of the lateral malleolus 
of· both hindpaws using an indelible pencil lightly wetted 
with water. Hind paw volumes were then determined to this 
mark using the apparatus shown in Fig. 2. The opposite 
page describes the working procedure for calibration of 
the plethysmograph. Once the machine was calibrated, each 
"hind paw was dipped thrice, from which an average could 
be calculat-ed. It was necessary to check the calibration 
of the instrument every 20 minutes. 
The rats were taken off food at -1 hr and orally 
dosed with the test drugs. The control groups received only 
the vehicle (aqueous 0.25% agar) at the constant dosage 
volume. One hour aftPr oral administration of the test 
5Phenylbutazone (SN 20911) Ciba Pharmaceuticals, 
New Jersey. 
6 sodium pentobarbital (Lot #816-1739), Abbott 
Laboratories. 
7carrageenin (!dent. #312503), Sea Plant Chemical 
Corp., Massachusetts. 
).A 
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INSTRUCTIONS FOR OPERATION OF PLETllYS~OCRAPF­
. (Beckman Typ-e RS D:;nograph) 
(Measurement of Rat Pedal Edema) 
Revised by Radhnkrishnan Iyer and Jeffrey S. Bohrman. August 1976 
1. Flip toggle switch ~ to "arteriaL" Dc!Jends on type .of transducer- you are using-
as to whether you flip to venous or arterial. 
2. Flip toggle switch B to "negative." 
3. Flip toggle switch c to "normal. 11 
4. Flip toggle switch D to "average." 
5. 1\.lrn knob E to "1 mv/crn." (approximate setting) 
6. Turn knob I to "x.l mv/cm." (approximate setting) 
7~ Flip toggle switch G to "out." 
8 .• Depress button,!! to "l '.IIIO./sec." 
9. Turn knob I to "operate" and allow at least 30 minutes, but prefer..ably. 
60 minutes- for machine wa.rm-up. 
10. Adjust mercury level in S shaped tube with the mercury level in ·the reservoir 
using the syringe which is filled with distilled water. 
11. Close the screw clamp which regulates the flow of water from the syri~ge into 
the transducer. 
12. Flip toggle switch ! to ''off" and turn knob N and position pen 6~ em. from 
top of paper. The kno~ N should be in the middle - approKimately. 
13. Flip toggle switch ! back to "negative" and tuJ:n knob 0 and position the pen 
~ em. from the top of paper. The knob Q should be in-the middle - approximately. 
14. Immerse the calibration rod to the 1 m1. mark. 
15. Turn knob 0 (should be approximately in the middle) and again po&ition pen 
to 6~ em. from top of paper. 
·16. lromerse ·the calibration rod to the 2 ml. roark. This should position the pen 
7 em. from the t"op of paper. If not, adjust to 7 em. by _adjusting the mercury 
level in 5 shaped tube. TI1e mercury level should be as. described in Step 10. 
If not, restart the calibration from Step 10. 
17. Continue to immerse c<llibraticn rod ·1n 1 ml. increments, turning knob I 
slightly to keep pen positioned at 0.5 em. intervals. 
18. Withdraw calibration rod. The pen s110uld c-ome to rest approximately 6 or ~ 
em. from. top of paper. 
19. Keep repeating steps 14 to lS un-til 1 ineari ty is achieved; each 1 mi. of rod 
equals _to 0.5 em. displacement on the paper. 
IMPORTftNT NOTE: Each person has differ~nt technique of operating, thus to prevent 
disparity in result-s.- only the investigator is to operate the 
machine. 
Fig . 2 . P e h mograph: Beckman Type RS d. nograph 
conn c cd to a Sta ham strain gauge pressure 
transducer (P23BB, 0-50 mm) . 
2 
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drugs, the rats received a subplantar injection of 0.1 ml 
suspension of 1% carrageenin in 0.9% saline in the right 
hind paw. At +5 min, recording of the paw volume was made 
after the carrageenin injection. This reading served as 
the actual '0' min reading and changes in paw volume with 
time was calculated relative to this value. The paw 
volumes were measured at time intervals of +30, +60, +~0, 
+120, +150, +180, +210, +240, and +300 minutes. 
Extracts D and F (see Fig. l) had shown interesting 
activity. Therefore it was desirable to undertake a de-
tailed phytochemical inve-stigation of the ext-racts D and 
F. For this purpose a large-scale extraction of the crude 
drug was carried out as described in the following section. 
LARGE SCALE EXTRACTION 
Based on the results of the preliminary experiments, 
two types of extraction procedures were carried out as 
desc-ribed below (see also Fig. 1). 
Method 1. Two Kg of powdered drug was macerated 
with cold methanol for 24 hr in a glass percolator (length 
21" and. ID 8°) and then continuously percolated with cold 
methanol in the dark. Percolation was carried out till a 
200 ml volume of the percolate on concentration gave a 
negative test with Mayer's reagent. The percolate (12 liters) 
was concentrated under vacuum at a temperature less than 
45°. The concentrated syrupy liquid (640 ~1) corresponded 
to a weight of 127 g of dry extract (10-ml of an aliquot of 
---- .... 
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the syrupy liquid when stripped completely of all the sol-
vent corresponded to 1. 9853 g of the dry residue). 
The concentrate was diluted with water to double 
the volume and acidified with 800 ml of 2N HCl, kept at 
5° for 24 hours and filtered. The filtrate was recycled 
three times to get a fairly clear .filtra.te. The residue 
was suspended in dilute HCl, digested thoroughly by warming 
to less than 45° and filtered. The washings were combined 
with the main filtrate and the combined filtrate was made 
alkaline with 28% NH4 0H to pH 10. The filtrate (2 liters) 
was divided into five portions. Each por~ion was extracted 
with CHC1 3 (3 X 200 ml). The chloroform extracts were com-
bined, dried over sodi urn sulfate and t ·he chloroform removed 
in vacuo to yield 8.5 g of a dark gummy residue. This ex-
tract was designated as extract D. 
Method 2. Seven Kg of powdered drug was loaded in 
three glass percolators (length 21" and ID 8 11 ) and macer-
ated with cold methanol, in dark, for 48 hours. The macer-
ated drug was next percolated to exhaustion with cold 
methanol. Percolation was continued till a 500 ml aliquot 
on concentration yielded a negative test with Mayer's re-
agent. A total of 128 liters of the percolate was collected 
over a total period of 25 days. The percolate was concen-
trated in a rotary evaporator at a temperature less than 
45° to a ftnal volume of one liter (6-ml aliquot on com-
plete removal of all solvent corresponded to a weight of 
2.74 g, representing 450 g of mcthanolic extract). The 
• 
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total extract was diluted with two liters of distilled 
water and acidified with 2N liCl to a _pH of 2.0. The 
aqueous acid solution was extracted with about three 
liters of petroleum ether (40-60°) and later followed by 
extraction with about five 1 i ters of ether. -The ether 
layer was reextracted with 2N HCl and the aqueous layer 
combined with the acidic aqueous extract. The whole 
aqueous extract was carefully basified with 28% NH4 ou 
to a pH o.f 9-10. The aqueous lay-er (seven liters) was 
divided into three portions and each portion extracted 
with ~hloroform (3 X l liters). The combined chloroform 
extract (20 liters) and petroleum ether extract were dried 
over anhydrous sodium sulfate, filtered and concentrated. 
The dry chloroform extract weighed 1_2 g. This- extract 
was d-esignated as extract F. The petroleum ether extract 
was designated as extract P (30 g). 
During the extraction, considera-ble emulsion forma-
tion was encountered. This was partly overcome by a) addi-
tion of saturated sodium chloride solution to the separatory 
funnel and b) by slight application of hot air on the out-
side of the separatory funnel with ~he aid of a hair dryer. 
SEPARATION A~~ PURIFICATION OF 
CO~STITUENTS OF EXTRACTS 
On the basis of preliminary phytochemical and hip-
pocratic screening, the two extracts F and P (Fig. 1) were 
thought to be of interest for detailed examination. Separa-
tion and purification of constituents of these two extracts 
....... _ 
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were therefore attempted. 
Chromatographic methods have been shown to be suit-
able for separation and purification of constituents of 
crude plant extracts (38). Of the chromatographic methods, 
TLC and Column Chromatography (CC) were chosen as the two 
most likely to succeed. 
Column chromatographic separation yields amounts 
of substances sufficient for characterization and testing. 
In order to develop proper CC systems, TLC was first in-
vestigated in detail, since results of TLC can often be 
applied to CC (38). Also, CC separation could be fol-
lowed by TLC .checks. 
Thin-Layer Chromatography (TLC) 
The extracts were spotted using capillaries drawn 
8 from melting-point tubes, on precoated plates. The 
9 spotted plates were transferred to glass chambers pre-
viously saturated with solvent vapor. All solvents were 
10 
reagent grade. After development for a distance of 16 em, 
the plates were removed from the chambers and air dried. 
The developed spots were visuali.zed by three methods - ex-
posure to short wavelength UV, spraying with Dragendorff's 
reagent and exposure to iodine vapors. ·rhese visualization 
Ohio. 
8E. Merck, Darmstadt, Germany. 
9
nesaga, Heidelberg, Germany. 
·
10ACS reagents, t1atheson, Coleman and Bell, Norwood, 
....... 
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procedures were carried out on each plate in successiont 
in the order given above. Spots observed after each ex-
posure were marked on the plates by a stylus. 
Th.e absorbents (plate coatings) were of 250 micron 
thickness and contained F-254 fluorescent indicator. The 
absorbents and developing solvents used are given below: 
Silica Gel 60 
a) Butanol: acetic acid.: water 40:10:50 
b) Cyclohexanone:chloroform:diethylamine 50:40:10 
c) Ethylacetate:n-propanol:ammonia 
d) Chloroform:diethylamine 
e) Methanol:carbon tetrachloride: 
acetic acid 
f) Chloroform:methanol 
g) Chloroform:methanol:diethylamine 
h) Chloroform:methanol:acetic ac·id 
i) Benzene:methanol 
j) Chloroform:met·hanol: diethylamine 
Aluminum Oxide 
4.0:30:3 
90:10 
28:92:1 
85:15 
86:4:10 
85:5:10 
80:20 
so :10:10 
a) Cyclohexanone:chloroform:acetic acid 45 : 45:10 
b) 2-Butanone:methanol:ammonia 60:30:10 
c) M~thanol:carbon tetrachloride: 
acetic acid 28:12 :·1 
d) Chloroform:methanol:acctic acid 25:65:10 
e) Chloroform:mcthanol:acctic acid 5:80:15 
·------
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Column Chromatography 
Extract D. A glass chromato~raphic column (5 X 50 em) 
was packed with a slurry of 400 g alumina (activity II) 
in chloroform. Extract D (8.5 g) was dissolved in minimum 
me thanol and about 20 g of alumina were added to the 
solution with stirring. The slurry was evaporated to dry-
ness in vacuo and the resulting yellow powder was applied 
to the top of the packed column. Development was carried 
out utilizing the gradient elution technique beginning with 
chloroform and followed by chloroform containing increasing 
amounts of methanol. Two hundred ml fractions were collected, 
concentrated and examined by TLC on silica gel GF uniplates11 • 
using chloroform:methanol:diethylamine (86:4:10) as the 
solvent system. The plates were dried, examined under 
short wavelength UV and s -prayed with Dragendorff 's reagent. 
Table II gives the result of the chromatography. 
Fractions 4 and 5 which yielded Dragendorff-positive 
spots on TLC were further rechromatographed on silica gel 
column. 
A 2 X 25 em glass column was packed with a slurry 
of 20 g silica gel 6o12 in benzene. Fractions 4 and 5 
from alumina column we re combined, dissolved in benzene 
and applied to the top of the packed column. Gradient 
11Analtech, Inc., Canoga Park, California. 
12EM Laboratories, Elmsford, NY. 
r ·---·------- -----·---- ----
---- ------ - ----- ----· ---·------ ; · , 
Table II: Col~ml'l chromatographic separation of extract D 
Weight of 
Fraction Solvent (s) Elutiot+ Dry Residue 
(no.) (ratio) volume (ml) · (g) Remarks 
1 chloroform (100.0) 500 0.6793 
2 chloroform 200 0.0664 
White crystals 
3 chloroform 300 0.3460 
4 chloroform:methanol (98:2) 1000 0.3645 Aikaloidal mixture 
5 chloroform:methanol (98:2) 2200 O.ti433 Alkaloidal mixture 
6 chloroform:methanol (95:5) 1000 
7 chloroform:methano1 (92:8) 1500 1.5534 
8 chloroform:methanol (88:12) 1000 
9 chlotoform:methanol (80:20) 1000 
10 chloroform:methanol (75:25) 3000 0.600 
11 chloroform :methanol (50:50) 1000 
12 methanol 1500 0.400 
Total volume of eluate: 14.200 liters w t-' 
Total weight of residue: 4.6529 g 
~ 
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elution was started with benzene and followed by increasing 
amounts of methanol and finally with methanol. Fifteen-ml 
fractions were collected and monitored by TLC on silica 
gel GF uniplates, using chloroform:methanol:diethylamine 
(86:4:10) as solvent. The spots were visualized as before. 
Table III gives the result of the chromatography. Attempts 
to obtain crystalline material from these fractions were 
not successful. 
Fractions 2 and 3 from the chromatography of extract 
D on alumina, gave white crystals on addition of methanol. 
This compound gave a positive Liebermann-Burchard test (39) 
and also a positive Salkowski test (39). This compound 
was therefore presumed to be a sterol _ It was later found 
to be present in the extract P also and was isolated as 
below: 
Extract P. The sterol suspected to be present in 
the extract D was found to be present in a substantial amount 
in the extract P. An attempt was therefore made to isolate 
this sterol by column chromatography of the extract P. 
A 5 X 50 em glass column was packed with a slurry 
of 400 g silica gel (activity II) in petroleum ether (40-
600). Twenty g of extract P was dissolved in sufficient 
methanol and 20 g silica gel added. The slurry was evap-
orated to dryness and the resulting yellow powder applied 
to the top of the packed column. Gradient elution was 
started beginning with petroleum ether . Fj.vc hundre d-ml 
fractions ~ere collected. The fractions were concentrated 
and examined on silica gel GF uniplates using three sol vent 
• 
T."" 
~ 
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Table III: Column chromatographic sepa!ation of fractions ~ & 5 from alumin~ column 
Weight of 
F.-action Solvent(s) Elution Dry Residue 
• 
(no. ) (ratio) volume (ml) (g) Remarks 
1 Benzene:methanol (99:1) 100 0.060 
2 Benzene:methanol (98:2) 100 0.050 
3 Denzene:methanol (98:2) 100 0.082 Alkaloidal mixture 
4 Benzene:methanol (97:3) 200 0.130 Alkaloidal mixture 
5 Benzene:methanol (88:l2) 300 0.054 Alkaloidal mixture 
6 Methanol 100 
7 Methanol:2%HC1 (95:5) 100 0.206 Alkaloidal mixture 
Total volume of eluate: 1000 ml 
Total weight of residue: 0.582 g 
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systems-benzene:petroleum ether (20:80), benzcne:petroleum 
ether (40:60) and chloroform. The plates after development 
were dried and visualized as before. Table IV gives the 
result of this - chromatography. 
Fractions 10 and 11 from the above chromatography 
mainly contained the sterol but could not be induced to 
crystallize even after prolonged standing. These were 
therefore comb~ned and rechromatographed over alumina. 
However again no separation or crystallization occurred. 
Therefore the combined extracts were again rechromatographed 
on silica gel. A 2 X 25 em glass column was packed with 
a slurry of silica gel in benzene. One g of the combined 
fractions was dissolved in a minimum amount of benzene and 
applied to the top of the chromatographic column. Elution 
was started with benzene. The first 1000 ml of the frac-
tion contained the sterol. The eluate on complete removal 
of all solvent left a colorless gum behind. This gum was 
crystallized from aqueous methanol as colorless plates. 
The crystalline substance was identified as 8-sitosterol. 
Extract F. Before large-scale chromatography was 
undertaken, it was thought desirable to find the ideal 
conditions for the chromatographic separation of the con-
stituents of the extract F ~ Earlier experiments on extract 
D had established that aluminum oxide was not the preferred 
adsorbent for separation. Hence it was thou~ht necessary 
to evaluate the merits of other adsorbents like silica gel 
along with various combinations of solvents for elution. 
To facrl.i tate this investigation, a series of small glass 
r--· ' ... ···----· 
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Table IV: Column chromatograhic seErat:i.on of extract P 
Solvent(s) Elution 
Fraction (no.) (ratio) volume (ml.) Remarks 
1 Petroleum ether 100 1000 
2 Petroleum ether !benzene (80:20) 1000 
3 Petroleum ether:benzene (60:40) 1000 
4 Petroleum ether:benzene (60:40) 2000 
5 Petroleum ether:benzene (20:80) 1000 
6 Benzene 100 1000 
7 Benzene:chloroform (80:20) iooo 
8 Benzene:chloroform (60:40) 1000 
9 Benzene:c~loroform (40:60) 500 
10 Benzene:chloroform (20:80) 500 sterol 
11 Benzene:chloroform (20:80) 1000 sterol 
12 Methanol 100 1000 
Total elution volume 12.00 liters c..v 01 
. . 
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microcolumns (1 x· 10 em) were prepared and 200 mg samples 
each of extract F were run. 
On the basis of TLC on silica gel GF uniplates and 
alumina GF uniplates, the following adsorberrts and solvent 
combinations were selected for this i .nvestigation: 
a) A glass microcolumn was packed with a slurry 
in benzene, of 10 g of alumina (neutral and low adsorptive 
capacity) prepared according to the procedure of Johns and 
Lamberton (40). Extract F was dissolved in minimum 
methanol and 3.0 g of alumina addad. The slurry was evapor-
ated to dryness and the dry powder applied to the top of 
the packed column. Elution was started with benzene and 
then followed by benzene with increasing amounts of methanol. 
Ten ml fractions were collected and examined on silica gel . 
GF uniplates with chloroform: acetone: dieth lv lamine (50: 40:10). 
b} A similar alumina c·hromatographic column was 
set up, but elution was started with benzene, followed by 
chloroform and finally with methanol. 
c) A glass microcolumn was packed with 10 g of 
silica gel (activity II) in benzene. Extract F was dis-
solved in minimum methanol and three g of silica gel (activ--
ity !!)"added. The slurry was evapo_rated to dryness and 
the dry powder was applied to the top of the packed column. 
Elution ~as started with benzene, followed by chloroform 
and methanol in that order. Ten-ml fractions were col-
lected and monitored by TLC using silica gel GF uniplates. 
d) A similar chromatographic column was set up 
• 
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as above, but elution was started with benzene containing 
increasing _proportion of methanol. 
e) A glass microcolumn was packed with a slurry 
of silica gel (deactivated) in benzene according to the 
procedure of Johns and Lamberton ( 40). Extract_ F was dis-
solved in a minimum amount of methanol and three g of silica 
gel (deactivated) added. The slurry was evaporated to dry-
ness and the dry powder was applied to the top of the packed 
column. Elution was started with benzene, followed by 
chloroform and methanol in that order. Ten-ml fractions 
were collected and monitored by TLC using silica gel GF 
uniplates. 
f) A similar chromatographic column was set up 
as above, but the elut -ion was started with benzene, fol-
lowed by benzene containing increasing proportion of methanol. 
From these experiments, it was concluded that CC 
of extract F on silica gel (deactivated) using benzene-
methanol as eluent would yield the desired separation of 
the constituents. Since further quantities of extract 
F were necessary, a second large-scale extraction of pow-
dered B. hopeana root was carried out according to the pro-
cedure outlined on page 26 . In this case 15 Kg of root 
powder was used and therefore quantities of solvents used 
in extraction had to be increased in proportion. At the 
end of the extraction, a red gummy extract F weighing 
23 -g was obtained. This quantity of the extract was then 
subjected to CC as below: 
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A 5 X 50 em chromatographic column was packed with 
a slurry Qf 400 g of deactivated silica gel 60 in benzene 
using the procedure of Johns and Lamberton (40). Extract 
F was dissolved in minimum amount of methanol and about 
30 g deactivated silica gel added. Removal of the solvent 
in vacuo gave a dry yellow powder which was applied to the 
top of the packed column. Gradient elution of the column 
was carried out beginning with benzene and followed by 
benzene containing increasing amounts of methanol and 
finally with methanol containing 1% HCl (98.2). Five 
hundred-ml fractions were collected. The fractions were 
concentrated and monitored by TLC as before for extract D. 
The individual fractions were combined on the basis of 
their TLC _patterns. The results were presented in Table V ~ 
Isolation of Scopoletin 
The residue from fractions 2 and 3 crystallized as 
white solid on addition of benzene-methanol (95.5). This 
solid was recrystallized three times from benzene-methanol 
(95.5) to yield an analytically pure sample. This sub-
stance was later identified as scopoletin, a known coumarin 
derivative. 
Using the chromatographic procedure described above, 
a partial separation of the components had been achieved. 
HoweverJ several of the eluate fractions from the CC were 
found to be mixtures of several components when moni to.red 
by TLC. Preparative TLC was used to further separate the 
components of these eluates. 
~- . . 
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Tn,ble V: Column chromato~ic separation of extract' F 
Weight of 
Fraction Solvent(s) Elution Residue Remarks 
(flO. ) (ratio) volume (rnl) (g) 
1 Benzene 4000 0.200 
2 Benzene :methanol (98:2) 3000 0.524 Scopoletin 
3 Benzene:methanol (96:4) 3000 1.611 Scopoletin 
4 Benzene:methanol (94:6) 3000 0.453 
5 Benzenc:methanol (92:8) 5000 3.400 
6 Benzene:methanol (90:10) 4000 2.365 Alkaloids 
7 Benzene:methanol (88:12) 3000 0.550 Alkaloids 
8 Benzene:methanol (85:15) 3000 0.876 Alkaloids 
9 Benzene:methanol (80:20) 4000 0.940 Alkaloids 
10 Benzene:methanol (70:30) 2000 0.408 
11 Benzene:methanol (50:50) 3000 0.697 
12 Methanol 3000 3.492 
w 
Total eluate volume = 40 liters tO 
Total weight of residue = 15.516 g 
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Preparativ~ Thin-Layer Chromatography 
(Isolation of Alkalo~ds) 
40 
Fractions 6, 7, 8 and 9 were found to be the major 
alkaloid-bearing fractions. Three Dragendorff-positive 
(alkaloidal) spots were observed when these were monitored 
by TLC on silica gel GF uniplates. These three spots 
were initially simply designated as Alkaloid I, Alkaloid 
II and Alkaloid III. From the ·tntensi ty of the Dragendorff-
positive spots~ it was concluded that alkaloid III was prob-
ably present in the highest quantity. Attempt was there-
fore made to isolate alkalojd III in a pure form using pre-
parative thin-layer chromatography on alumina plates. The 
solv-ent sy·stem for this chromatography was selected after 
extensive experimentation with various combinations of sol-
vents so as to give good separation between the components. 
The solvent systems which were found suitable for t.he de-
sired separation along with the Rf values of the alkaloids 
are present in Table VI. 
Isolation of Alkaloid III. A series of preparative, 
precoated aluminum oxide plates (150 F-254 PLC, 150 microns 
thick) 14 were activated for 10 minutes at 100° . The plates 
were alxowed to cool to room temperature and stored in a 
desiccator before use. The residue from fractions 8 and 9 
(Table V) were combined, wci~hed, and dissolved in minimum. 
14scientific Products, Menlo Park, California. 
r 
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Table VI: Rf values of the alkaloids I, II, Ilia 
Rf Values 
Solvent Sy~tem Alkaloid I Alkaloid II Alkaloid IIJ 
Chloroform:methanol (95:5) 0.62 0.56 0 ; 37 
Acetone:chloroform:methanol 
(5:90:5) 0.55 0.42 0.21 
Benzene:chloroform:methanol 
(5:90:5) 0.66 0.56 0.38 
aAdsorbent: Precoated aluminum oxide plates (type E), F254 , abrasion resistant, 20 X 20 em. · 
>flo 
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of chloroform:methanol (95: 5). The solution was unifo··rmly 
applied 2.0 em from the base of the plate with the aid of 
15 
a streaker. Up to 60 mg of the sample was applied to 
each plate. The plates were air dried and allowed to de-
velop in benzene:chloroform:methanol (5:90:5) for a dis-
tance of 16 em. After the first development, the plates 
were air dried and redeveloped in the same solvent system. 
After two developments, the plates were air dried and 
examined under short wavelength UV. The band corresponding 
to Rf 0.37 was carefully scraped off, loaded in a small 
glass column, and eluted with chloroiorm:methanol (80:20). 
From fractions 8 and 9, 0.250 g of the crude alkaloid III 
was obtained. The preparative TLC was repeated on this 
material using the same conditions as above to yield 0.150 g 
of pale yellow gum. This material could not be induced to 
crystallize even though it appeared as a single spot when 
examined by TLC in several solvent systems. To obtain 
crystalline material, an attempt was made to prepare the 
hydrochloride of the free base as detailed below. 
To a solution of the free base in anhydrous methanol, 
few drops of concentrated HCl were added and the solvent 
removect~in vacuo. The resulting colored material was dis-
solved in minimum anhydrous methanol and hot benzene was 
added till cloudiness appeared. The solution was allowed 
15Kontes Glass Company, Vineland, New Jersey. 
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to stand for a few days. However, no crystals separated. 
This led to the conclusion that additional puri·fication 
was required. The free base was recovered from the hydro-
chloride as specified below. 
To the boiling solution of the hydrochloride in 
·methanol, a few drops of ammonia was added. The solvent 
was removed in vacuo to yield a colored gummy ma.terial. 
A small glass column of deactivated silic.a gel (prepared 
as before) was set up in chloroform and the colored gum 
was applied to the top of the column as a solution in 
chloroform. .Elution was started with chloroform followed 
by increasing proportion of methanol. Ten ml fractions 
were collected and monitored by TLC on silica gel GF uni-
plates, using chloroform:acetone:diethylamine as the de-
veloping solvent and Dragendorff reagent as the detecting 
agent. Elution with chloroform:methanol (85:15) gave single 
spot fractions. Concentration and complete removal of the 
solvent in vacuo left behind a light yellow gum. This 
residue crystall~zed from acetone-petroleum ether to yield 
0.060 g of pale yellow crystals of a substance which was 
designated as alkaloid III. 
Isolation of Alkaloid I : Fraction 6 (Table V) was 
observed to contain this alkaloid and was therefore sub-
jected to preparative TLC procedures as outlined for 
alkaloid III. The solvent for development however was a 
mixture of acetone:methanol : chloroform (5:5:90}. The 
r 
I 
I 
I 
I 
' 
L 
44 
band at Rf 0.55 was due to alkaloid I and was scraped off 
and eluted by chl6roform: methanol (90:10) as previously 
described. Removal of the solvent yielded a p~le orange 
residue. In order to further purify this residue, it was 
rechromato-graphed by preparative TLC using acetone: 
methanol:chloroform (35:5:160) to obtain a pale yellow 
gum. Although monitoring by TLC showed only one spot, no 
crystallization could be achieved. This pale yellow gum 
was therefore rechromatographed by CC on silica gel 
(deactivated) with chloroform:methanol (90:10) as eluent. 
Removal of solvent from eluate gave a colorless gum. Ad-
dition of acetone-petroleum ether to this gum gave white 
crystals of Alkaloid I (0.020 g). 
Similar procedures were carried out on eluate frac-
t ion 7 (Table V), s ·ince it contained Alkaloid I I. Only 
1-2 mg of pure substance was recovered. 
High Pressure Liquid Chromatography 
A qualitative study of the purity of the fraction 
8, obtained from the chromatography of e xtract F, was car-
ried out using a Perkin-Elmer hi gh pressure liquid chroma-
tography equipment. The conditions of the chromatography 
are as described ·below: 
Column dimension: 25 X 0.26 em 
Adsorbent: ODS 
Elution solvent: Ac e tonitrile:water (20:80) 
Flow rate: 1. 5 Ml/min 
Operation: Re verse phase 
.... 
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Operating Conditions: 
Instrument: Perkin-Elmer 
Column: ODS (25 X 0.26) 
Eluent: Acetonitril-e: 
wat.er (20: 80) 
Flowrate: l. 5 ml/min. 
Operation: Reverse _phase 
Detector: 
Injection 
Vol.: 
Pressure: 
5 
UV (multi-
wavelength) 
11 lll 
3000 Psi 
Fig. 3. High pressure liquid chromatogram of a 
fraction of impure hopeanine (peak 5 
corresponds to hopeanine) 
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De-tector: UV (multi wavelength) 
Injection volume: 11 lJl 
Operating pressure: 3000 Psi. 
After the injection of the sample, the chromato-
gram was carried out and the eluents collected as they 
emerged in separate flasks. The eluents were concentrated 
and examined by TLC. By this procedure it was concluded 
that the fraction 8 contained at least six components and 
that on a high pressure liquid chromatogram (run under the 
above conditions) Alkaloid III corresponded to peak 5 
(Fig. 3). However this e .quipment was not available for 
further experimentation. 
Spectral Analysis 
The identity and characterization of the pure com-
pounds were achieved by using various physico-chemical 
(spectral) methods of analysis, melting point determina-
tion and whenever pos.sible de.rivatization. The instru-
ments employed and conditions for spectral analysis were 
as given below: 
a) UV 
b) IR 
Perkin-Elmer UV-VIS 202; compounds 
dissolved in spectral grade me·thanol. 
Perkin-Elmer IR 137 and 337B; spectra 
obtained as KBr pellet (solid compounds) 
or dissolved in spectral grade CC14 . 
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c) 1H NMR 
d) 13c NMR 
41 
JOEL, 100 MHz spectrophotometer. 
Tetramethy1si1.ane (TI.IS) as internal 
standard. Chemical shifts reported in 
o units .. 
Bruker, WH-90. Pulse flip angle 
33°, repetition rate 0.7 seconds, spec-
tral width 6024 H~ and computer limited 
resolution of 0.735 Hz. 
e) Mass Spectrum (MS) 
Low Resolution - UCB , MS-12 operating 
at 70 ev. 
High Resolution - UCB, SSL double focus-
sing 
Chemical Ionization- Dupont, 21491 B EI/CI. 
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RESULTS AND DISCUSSION 
PRELIMINARY CHDt !CAL SCREENING 
Preliminary phytochemical screening was undertaken 
to confirm the reported presence of alkaloids in Brunfelsia 
hopeana. Definite turbidity was observed when the methanolic 
and chloroform extracts of the whole root were tested with 
.Mayer's reagent. 
In order to estimate the number and nature of 
the alkaloids present in the plant, so that a suitable ex-
traction procedure could be developed for isolation of the 
constituents, a series of extracts obtained by extraction 
of the root powd·er with hot and cold mDthanol, aqueous 
methanol, and water were subjected to TLC on silica gel. 
On spraying with .Dragendorff 1 s reagent, the hot and cold 
methanol and aqueous methanol extracts showed the presence 
of two or possibly three alkaloids as noted by the appear-
ance of discrete Dragendorff-positive orange spots on the 
TLC plate. The hot and cold aqueous extracts did not show 
any Dr.a.gendorff-positive spots. The nature of the alka-
loids was predicted by testing the chloroform extracts. 
These again showed the presence of orange spots on the 
TLC. This indicated that the alkaloids were probably 
secondary or tertiary in nature. No evidence for the presence 
48 
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of quarternary alkaloids could be found. When Mayer's re-
agent was added to a solution of the aqueous extract at 
alkaline pH, no turbidity was observed. These are there-· 
fore probably absent in the root of B. hopeana. 
HIPPOCRATIC SCREENING 
In the present investigation, the powdered crude 
drug and its various extracts (Fig. 1) were subjected to 
hippocratic screening. Malone and Robichaud (37) state 
that "the goal of Hippocratic screen is to determine one 
lethal dosage, one completely ineffective dosage and at 
least three effective log dosages between these two 
levels." They also noted that "the· amount of test material 
needed to complete an evaluation should be small; yet for 
a natural product program, t ·he screen must be designed to 
utilize equally well either chemically pure or grossly 
crude material in order that extract f"ra..ctionation may be 
followed pharmacologically. If a pure chemical or crud·e 
materialis not active intraperitonially in agar suspension 
at 100 mgfKg and 1 gmfKg, respectively, it will eventually 
prove to be not feasible commercially and therapeutically. 11 
Observations after intraperitonial injection were 
recorded on the hippocratic screen work sheets described 
by Malone et al. (Fig. 4) (37). All references to time 
refer to the time after injection when the specified symptoms 
were first seen. Practical difficulties in suspending the 
test samples in agar prevented the administration of dosages 
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higher than 1 gm{Kg. Results of the screen on the whole 
root and. its various ·extracts are given below, followed 
by summarization of the observations. 
Powdered Whole Root 
100 mgjKg: 
562 mgfKg: 
1000 mg/Kg: 
+10 Minutes: slight decrease in motor ac-
tiv.ity and mild analgesia lasting for about 
an hour. +2 Hours: Animal appeared grossly 
normal. 
+10 Minutes: decrease in motor activity, 
mild respiratory depression, and mild llnal-
gesia lasting for about two hours. +30 
Minutes: slight tail erection, increase in 
pupil size, pilomotor erection, and startle 
sensitivity. Personality of the animal 
appeared grossly normal. 
+10 Minutes: decrease in motor activity, 
loss of grip strength (hind legs followed 
by forelegs), mild analgesia, and mild 
respiratory depression lasting for about 
two hours. +30 Minutes: fine body tremors 
and increase in pupil size. Personality 
of the animal changed from normal to pas-
sive. +2.4 Hours: animal appeared grossly 
normal. 
Summary. The minimum dose producing definite symp-
tomology was. found to be 100 mg{Kg. When anir,;als were dosed 
r 
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between 100 mgfKg and a nonlethal dose of 1000 mgfKg, the 
following symptoms were found to be dose-related: 
a) decrease in spontaneous motor activity 
b) respiratory depression 
c) mild analgesia 
d) hypersensitivity to sound 
e) increase in pupil size 
Extract B 
178 mg/Kg: +10 Minutes: loss of grip strength (hind-
legs followed by forelegs), slight enophthalmos, 
and pilomotor erection lasting for about 
two hours. +15 Minutes: decrease in motor 
activity, decrease in respiratory rate, in-
crease in pupil size, and watery salivation 
lasting for about two hours. A personality 
change from normal to passive was observed. 
+24 Hours: some loss of grip strength still 
present (hind legs only); otherwise animal 
appeared grossly normal. 
Surrunary~ The minimum let.hal dose was observed to 
be 1000 mg/Kg. All symptoms noted with the whole root 
dose of 1000 mg}Kg could be seen at a dose level of 178 
mg/Kg, indicating eoncentration of activity. At the lethal 
dose level of 1000 mgJKg, Cheyne-Stokes respiration and 
total paralysis were noted. Autopsy revealed that death 
could have occurred d.ue to respiratory fai 1 ur~, since the 
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heart was beating in a coordinated fashion. 
Marc C 
100 mgfKg: 
1000 mgfKg-: 
No gross symptoms were apparent. 
+15 Minutes: slight decrease in respiratory 
rate and some increase in pupil size; other-
wise animal was grossly normal. 
Summary. .At dose levels of 1000 mgfKg, this 
material induced no grossly apparent symptomology. This 
indicated that the activity associated with the whole root 
had been efficiently extract ~d by menthanol. 
Extract D 
100 mg/Kg: 
316 mgfKg: 
+10 Minutes: decrease -in motor activ-ity, 
mild analgesia and decrease in respiratory 
rate. +15 Minutes: loss of gr~p strength 
(hindlegs followed by forelegs), fine body 
tremors,increase in pupil size, and a per-
sonality change from normal to passive. 
+30 M.inutes: some st e reotypic behavior, in-
creased depth of respiration,enophthalmos, 
and palpebral ptosis. All of the above 
symptoms persisted for approximately two 
hours. +24 Hours: some loss of grip strength 
(hind legs) still present; otherw-ise grossly 
normal. 
+10 Minutes: decrease in motor activity, 
decrease in respiratory rate, and decrease 
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in respiratory depth lasting for about two 
hours. +15 Uinutes: mild analgesia, 
enophthalmos, palpebral ptosis, watery 
salivation, piloQotor erection lasting for 
about two hours. Some stereotypic behavior 
characterized by the animal sitting in a 
corner with its f ·orelegs lifted up and 
scratching the mouth and facial region. 
Hypersensitivity to sound and touch was also 
present ~ +30 Minutes: mild ·body tremor, 
hypothermia (2° fall in temperature) r and 
pilomotor er e ction lasting for approximately 
two hours. +24 Hours: loss of grip strength, 
slight tail erect.i_on, some ptosis, and a 
decrease in respiratory rate were still 
present. 
Summary. Responses qualitatively similar to those 
previously seen but mo.re pronounced were observed, at doses 
indicated, namely 
a) decrease in motor activity 
b) respiratory depression 
·c) mild analgesia 
d} hypersensitivity to sound 
e) increase in pupil size 
f) salivation 
g) lacrimation 
h) hypothermia 
i) pilomotor erect·ion 
Extract E 
1000 mgfKg:: 
Extract F 
178 mg/Kg: 
316 mgfKg: 
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+15 Minutes: slight decrease in respiratory 
rate and some increase in pupil size; other-
wise the animal was grossly normal. Even 
at this dose level the material induced no 
apparent symptomology. 
+10 Minutes: slight decrease in motor 
activity. +15 Minutes: mild analgesia, in-
crease in respiratory depth with decrease 
in rate, increase in pupil size. +30 ~inutes: 
decrease in motor activity more pronounced, 
pilomotor erection, some hypothermia, change 
in personality from normal to passive. These 
symptoms persisted for about two hours. 
+24 hours: animal grossly normal. 
+10 Minutes: slight decrease in motor ac-
tivity, and grip loss (hindlegs followed by 
forelegs). +15 Minutes: mild analgesia, 
increase in respiratory depth, fine body 
tremors, increase in pupil size, so:r.c stereo-
typic behavior and hypothermia (1° fall in 
temperature). +30 Minutes: pronounced de-
crease in motor activity, pilor:1n to.r erec-
tion, diuresis, change in personality from 
normal to passive, pronounced hypothermia 
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(5° fall in temperature), and stereotypic 
behavior. Also noted were pinkish colora-
tion of facial region and a tendency to 
hold back its ears. All of the above symp-
toms persisted for about two hours. +24 
Hours: some grip loss (mainly of the hind 
legs) and fine body tremors were sti_ll 
present; otherwise grossly normal. 
Summary. T-he minimum lethal dose was found to be 
562 mg/Kg. When animals wer2 dosed between 100 mgfKg and 
562 mg/Kg, the following symptoms were found to be dose-
related: 
a) decrease in spontaneous motor activity 
b) decrease in respiratory rate with increase 
in depth 
c) analgesia 
d) fine body tremors 
e) increase in pupil size 
f) pilomotor erection 
g) lacrimation 
h) hypothermia 
Lethality at dose lev-el of 562 mgfKg occurred between one 
and two days, hence the exact cause of death could not be 
ascertained .. 
Scopoletin 
100 mgJKg: 
No symptoms were apparent; animal remained 
j 
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i 
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grossly ·normal. 
At this dose level no symptoms were apparent. Ac-
cording to Malone and Robichaud this observation indicates 
no significant phamacological acti v·i ty. 
Discussion 
As pointed out in the .introduction, Brandl (20) 
in 1885, had published on the gross pharmacology of a pro-
duct "manacine," isolated from manaca (B. hopeana) root. 
In spite of the interesting folkloric medicinal use of 
this plant, this is the only pharmacologic study pub-
lished so far. 
The present hippocratic screen of the crude drug 
powder and its extracts showed interesting pharmacological 
activity. The extraction procedure concentrated the ac-
tivity especially in the extract F. This extract produced 
a qualitatively unique central nervous system depressant 
action characterized by a reduction in motor activity, fore-
leg and hind leg grip loss and hypothermia. The symptoms 
noted within the lower doses of the whole root and the 
extracts were as follows: 
a) decrease in motor activity 
b) foreleg and hind leg grip loss 
c) mild analgesia 
d) mild hypothermia 
Further separation and purification of extract F 
yielded Alkaloids I, II, III and scopoletin. Scopoletin 
had no sign~ficant pharmacological activity. Presumably 
----' 
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the alkaloids would concentrate the activity of the extract 
F. However the low recovery of' total quantities of pure 
compounds precluded their use in hippocratic and anti-
inflammatory screens. 
ANT I INFLA~IMA TORY SCRE_EN ING 
The folkloric medicinal uses of Brunfelsia and the 
signs and symptoms observed during hippocr~tic screening in-
dicated that extract F should be further examined for its 
antiinflammatory action. The procedure of Van Arman et al. 
(37) was selected for this screening. Inflammation was 
induced in the rat paw by injection of carrageenin and the 
degree of inflammation was measured by a method similar to 
that described by Winter and Nuss (41). The reduction of 
inflammation on oral administratio-n o .f an antiinflammatory 
agent can be conveniently observed in this method. 
The Table VII shows the mean injected paw volumes 
of the control and treatment groups as measured by the 
plethysmograph, at the specified time intervals. The dif-
ference between the mea·n paw volume at a s pecific time and 
the mean volume at +5 minutes is a mea s ure of the degree 
of inflammation. 
The significance of differences betwe en test groups 
was assessed by Dunnett's '! 1 test (42, 43). It is seen 
that (Table VIII), there exists a significant difference 
(p < 0.05) in the degree of inflamm::Ltion between the con-
trol animals and the animals ~hich receive d the extract F 
Table VI I: Effects of drut; treatrnent on carrageenin-induced hind paw swelling on rats 
Mean hind paw volume, ml ~ b Treatment 1 S.E.-
(Dosage)~ 0 +5 +30 +60 +90 +120 +150 +180 +210 +240 +270 +300 
Control 0.71 0.97 1.11 1.21 1 . 26 1.47 1.58 1.62 1.63 1~55 1.49 1. 43 
(5 ml/Kg) + 0.03 0.03 O.OG 0.07 0.08 0.09 0.07 0.07 0.07 0.07 0.06 0.06 
-
Chloroform 0.77 0.90 1. 04 i. 03 0.95 l. 06 1.19 1. 27 1. 29 1. 29 1. 26 1. 23 
Extract {F) + 0.04 0.04 0.05 0.06 0.06 0.05 0.07 0.06 0.06 0.07 0.05 0.05 
-(100 mgfKg) 
Phenlybutazone 0.76 0.91 1. 06 i.l3 1.14 1.12 1.18 1. 27 1. 34 1. 27 1. 33 1. 23 
(100 mgfKg) + 0.03 0.03 0.05 0.06 0.06 0.06 0.06 0.06 0.07 0.05 0.07 0.10 
-
aA constant dose volu~e of 10 ml/Kg was utilized for the oral administration. 
~Each treatment group represents ten animals. 
--·--, 
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Table VIII; Effects of drug treatment o~ carrageenin-~nduced hind paw swelling on rats 
Mean Paw Volumez ml. + 1 S.E.~ (Min.) 
Treatment 
(IJosage) +30 +60 +90 +120 +150 +180 +210 +240 +270 +300 
Control 0.15 0.24 0.29 0.50 0.61 0.64 0.65 0.58 0.52 0.63 
(5 ml/Kg) +0.03 +0.05 +0.06 +0.08 +0.07 +0.06 +0.01 +0.07 +0.05 +0.06 
Chloroform 0.14 0.16 0.16 0.17£ 0.29£ 0.37~ 0.40~ b.45 0. 362. 0.32~ 
Extract (F) +0.03 +0.04 +0.04 +0.04 +0.05 +0.05 +0.04 +0.03 +0.03 +0.02 (100 mg/Kg) 
Phenylbutazone 0.15 0.23 0.23 0.212. 0.27b 0.36~ 0.43~ 0.36~ 0.42 0.37~ 
+0 ~ 03 +0.04 +0.05 +0.05 +0.05 +0.05 +0.07 +0.06 +0.06 +0.09 
~Represents the mean differences between volume at a specific time, minutes post-
injection, and the volume at +5 minutes. Each treatment group represents 10 rats. 
bSignificant difference between the effects seen in the control a~d treated animals 
at 0 •. 05 level of probability. 
-------( 
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treatment, at time intervals of +120, +150, +180, +210, 
+270, and +300 minutes. In case of the test group which 
received the phenylbutazone· treatment such differences 
were apparent at time intervals of +120 +150 +180 +210 
' ' ' , 
+240, and +300 minutes post injection. It is seen there-
fore that at equal oral dose levels of 100 mgjKg, extract 
F is .as effectiv.e as phenylbutazone in reducing carrageenin-
induced pedal edema. In both instances, the onset of ef-
fects were apparent two hours after pedal injection and 
_persisted for at least three hours thereafter. 
CYTOTOXIC ACTIVITY 
The results of the experiments on testing the 
cytotoxic activity oi the extracts B and F are recorded 
in Tables IX and X. The plot of cell population VS time, 
extract F, is shown in Fig. 5. Analysis of the results 
obtained with extract B showed that no correlation could 
be derived between control and treated cells. Thus this 
total methanolic extract (Fig. 1) was of very little fur-
ther interest in this regard. 
Extract F showed some apparent difference s between 
control and treated SV 3T3 cells. However, the data avail-
able could not be used to obtain significances of these 
apparent differences. The control and treated 3T3 cells 
did not show any apparent di~ferences. Any further investiga-
tions were precluded due to lack of test materials. 
Table lX~ Effect of extract F on the growth of 3T3 and___g_3T3 cells in 
culture 
3T3 SV 3T3 
Day c~ t.§. c t 
1 178~ 211 362 205 
2 340 274 636 213 
3 379 545 1960 443 
4 623 400 11480 582 
5 713 506 confluent 0 
-
a 
-c = Cont r ol group 
b 
-t = Treatment group 
cEach of the values in the above table represents the cell count ip 100 ~1 of 
solution as recorded by the Coulter Counter and is the mean of three readings 
per sample. 
- ·-· 
en 
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Table X: Effect of extract B on the g!owth of 3T3 and SV 3T3 cells in culture 
3T3 SV 3T3 
Day c a b d c b d 1 e a e-
1 594! 594 594 594 594 404 404 404 404 404 
2 4541 2191 2110 1f)91 2002 1021 614 664 667 520 
3 11625 9052 6639 10967 10460 1604 1041 1425 991 1022 
4 ------------confluent------------- 1554 928 1276 1425 970 
5 ------------confluent------------- 1990 2085 1451 1857 1602 
6 
----------------------------------
2150 1842 1656 1532 1856 
!Each of the values in the above table represents the cell count in 100 Pl of 
the solution as recorded by the Coulter Counter and is the mean of three 
readings. 
lc,a,b,d anq e are the treatments representing 0, 50, 100, 200, and 400 pgfml 
concentration of the extract, respectively. 
--- ··- .. 
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Fig. 5. Effect of extract F on the growth of normal 
and transfoTmed cells, in culture. 
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SEPARATION., PURIFICATION AND 
CHARACTERIZATION OF CONSTITUENTS· 
The crude screening procedure of Taylor (31) had 
67 
shown that "alkaloids" were present in the crude extract. 
This procedure also indicated that the ''a lltal o ids., were 
being extracted in extract Y (Fig. 1). The TLC procedure 
had shown the presence of three Dragendorff- and iodine-
positive spots in extract F. These were therefore desig-
nated as Alkaloid I, II and III (Fig. 6). 
Since, in the present investigation, major atten-
tion was devoted to these three alkaloids, the CC procedures 
were developed to achieve their separation and purification. 
Tbe other components were obtained serendipitiously. 
B -Sitosterol 
This ubiquitous plant sterol crystallized from 
the CC fractions 10 and 11 from extrRct P (Table IV). 
The identification of this constituent was based on the 
following data, which was identical to those of an authentic 
16 
sample. 
a) m.p. 136-137°, mixed m.p. 136-138° 
b) a.D -33° at 22°C 
c) Positive Liebermann-Burchard and Salkowski 
reactions. 
d) IR, UV and MS (Fig. 7) 
16supplicd by Dr. H. Miles, University of Mississippi. 
..... · 
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Solvent front 
15 '" 
{) ---- ·----1---- Alkaloid I . 
10 .• 0 ------------ . .Al!-caloid II 
. ·o ------- ---- Alkaloid I I I 
Fig. 6. Diagram of TLC separation of alkaloids from 
extract F. Alumina Type T, with F254 • 0.25 mm. Solvent system-Benzene:chloroform:me~hanol (5:90:5}. 
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Scopolet"in 
Fractions 2 and 3 (Table V) of CC of extract F 
yielded 0.5 g of white crystalline material (m.p. 204°). 
70 
The physico-chemical characteristics of this compound were 
identical to those reported for scopoletin (44). Mors had 
previously isolated and characterized scopoletin from 
various speciesof Brunfelsia including B. hopeana. The 
spectra of scopoletin are presented in the followi.ng 
pages (Fig. 8, 9). 
C-13 NMR. 13 To our knowledge the C NMR spectrum 
of the scopoletin -had not been previously reported. There-
fore this spectrum is discussed below: 
The wide-band 1n decoupled spectrum of scopoletin 
(Fig. 10) indicated the presence of 10 peaks, consistent 
with the ·pres-ence of 10 different carbons in the rr.olecule. 
The single frequency 1u decoupled spectrum of scopoletin 
showed the pr-esence of one quartet (-CH3 ), four doublets 
(-CH). and five singlets (non-protonated carbons). For 
discussion's sake, the signals can be divided into four 
regions characteristic of different types of carbon atoms. 
T . t. f 3 he first region, from 0-50 ppm, character1s 1c o sp 
carbon atoms bonded to carbon atoms;the second region, 
3 from 50-100 ppm, characteristic of sp carbon atoms 
bonded to heteroatoms-; the third reg-ion, from 100-150 ppm, 
2 characteristic of sp carbon atoms not bonded to hetero-
atoms; the fourth region, from 150-200 ppm, characteristic 
-
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of carbonyl carbons and aromatic carbons bound to oxygen 
(45). 
In case of scopoletin, no signal is found in the 
region between 0 and 50 ppm, thus indicating that there 
3 
are no sp carbon atoms bound to carbon atoms. In the 
region between 50 and 10 ppm, one _peak was observed at 
3 56.5 o indicating that it corresponds to an sp carbon 
bonded to a heteroatom, in the present case, oxygen. In 
the single frequency 1H decoupled spectrum, the peak at 
56.5 & appeared as a quartet. These two observations made 
it possible to attribute the signal at 56.5 6 to an -OCH3 
group. 
In the region between 100 and 150 ppm, six peaks 
were observed. Of these, the signals at 103.6, 108.6, 
2 111.5 and 112.3 o are part of sp carbons not bonded to 
heteroatoms. The assignments of these shifts to carbons 
8,5 and 10 (Table XI) were made using substituent chemical 
shift additivity principle (SCS principle) for hydroxy and 
methoxy substituents· on the benzene ring. According to 
this principle, for a substituent such as methoxy or 
hydroxy, the ortho and para position o values are shifted 
to higher field and that of the carbon of attachment to 
lower field, while the meta substituent is not much dif-
ferent from benzene (128.5 6) (46). Carbons 5 and 8 appear 
as doublets in the single frequency 1H d ccoupled spectrum 
and are ortho to the methoxy and hydroxy groups at 6 and 7 
positions, r~spectively. These carbons will hence be 
1 
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shifted -14.4 and -12.7, respectively, relative to benzene 
(46). Carbon 10 is para to the 7-hydroxy group and hence 
will be expected to appear at higher field. When these 
expectations are coupled with the values reported for 
coumarins (47, 48)~ it is possible to assign the peaks 
at 103.6, 108.6 and 111.5 6 to carbons 8,5 and 10 respec-
tively. The peak at 112.3 o can then be assigned to car-
bon 3 which is the a carbon of an a, f3 uns-aturated ketone 
(lactone) system. 
The signals at 144.8 and 145.9 also refer to sp2 
carbons. The one at 144.8 o appears as a doublet in 
single frequency decoupled spectrum and evidently must 
be attributed to a carbon bearing a single hydrogen. Thus 
this signal can be assigned to carbon 4 which is also the 
B carbon of the a S unsaturated ketone (lactone) system. 
The signal at 145.9 which appears as a singlet in the 
spectrum is then assigned to carbon 6. 
Of the remaining three signals, the ones at 150.5 
and 151.6 appear as singlets in the single frequency de-
coupled spectrum and are assigned to carbons 9 and 7, 
respectively, by comparison with the values reported for 
hydroxy coumarins (48). The signal at 163.2 is charac-
teristic of carbonyl carbon in a five or six membered 
lactone system. Thus this peak could be assigned to the 
carbonyl group. Table XI lists the complete assignments 
for carbons in scopoletin. 
J 
Table XI: 13c .I'<'MR data for sco-poletin (1) (22.62 MHz, 
CDCl 3-co3oD) 
HO 
1 
Chemical Shift Signal Assignment 
76. 
(ppm from TMS) multiplicity Group (carbon number) 
163.2 s 0-C=O 2 
151.6 s HO-C=C 7 
150.5 s 0-C=C 9 
145.9 ·s CH30-C=C 6 
144.8 d -C=C 4 
112.3 d -C=C 3 
111.5 s -C=C 10 
108.6 d -C=C 5 
103.6 d -C=C 8 
56.5 q -OCH3 
11 . 
I 
I 
J 
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Alkaloid I 
As pointed out in the experimental section the 
three "alkaloid" components were separated by CC and pre-
parative TLC procedu-res, in pure crystalline form. 
The spot corresponding to the Rf 0.55 (~able VI), 
on elution on preparative TLC gave 0.020 g of pure alkaloid 
I. The yield calculated on the basis of dried powdered 
·root of B. hopeana was 1. 4 mgjKg. 
Since the quantity of available pure compound was 
very small, characterization of this compound remains in-
complete. 0 It had a m.p . 178-180 , and a molecular weight 
315 {determined by chemical ionization mass spectrometry) . 
1 The H NMR spectrum in CDC1 3 shows (Fig ·- 11 ) no exchange-
able protons. The PMR spectrum on gross analysis shows 
the possibility of an -N-CH3 group (o 3.4). 
Alkaloid II 
This compound from extract F crystallized from 
preparative TLC eluate of the spot corresponding to Rf 0.42 
(Table VI). The total quantity of pure recrystallized 
substance obtained was 2 mg. This calculates to a yield 
of 0.14 mgfKg of crude drug powder. 
No further characterization of this constituent 
was possible. 
Alkaloid III (Hopeanine) 
This compound corresponding to the spot of RF 
0.38 (~able YI) was recovered in pure crystalline form in 
,_________ 
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• 
~ 
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1 Fig. 11. 100 MIIz II NMR spectrum of Alkaloid I in CDCl- 3 
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the total yield of 0.060 g calculating to a yield of 4 mg/ 
Kg of dried root powder. The pale yellow crystals had a 
0 
m.p. 164-5 . The purity of the compound was established 
by TLC on silica gel and alumina plates using various 
developing solvent systems (Table VI). In each case, only 
one single Dragendorff-positive spot was observed. The 
total amount of substance available, although small, made 
it possible to determine its structure by the use of special 
methods which are either non-destructive or require only 
very small samples. The many classical, destruct.ive, chemical 
methods of analysis were precluded by the limited quantity 
available. 
Structure of Alkaloid III (Hopeanine). As will be 
seen in the ensuing discussion, the compound initially desig-
nated as Alkaloid III is a new chemical entity, so far un-
reported in literature. Since it is obtained from 
Brunfelsia hopeana, alkaloid III was named "hopeanine." 
In the following discussion, this compound will be referred 
to as hopeanine. 
The IR, UV and 1H N!IIR (PMR) spectra of hopeanine 
are given in Figs. 12, 13 and 14, respectively. Only some 
gross information cou.ld be obtained by analyzing these 
spectra. The PMR spectrum was expected to give useful 
information regarding the number of protons and nature 
(environments) of each proton. However, the spectrum was 
complex and was of only limited use. The pertinen~ obser-
vations o.:f spectral analysis are summarized below ( 49,50). 
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UV -- a. Strong, broad absorption around 295 nm 
{conjugate double bond system) 
b. Plateau-like absorption around 215 nm 
c. ·No bathochromic shift on addition of 
alkali (phenolic -OH absent) 
IR -- a. Strong absorption arou-nd 3400 cm-
1 
(-NH or -OH group present) 
b. 
c. 
d. 
-1 
Strong absorption at 2950 em 
(aliphatic -CH stretching) 
-1 
Strong broad absorption around 1620 em 
(-C=N or -C=C present) 
No absorption between 1640 ·to 1800 cm-l 
(-C=O most likely absent) 
PM.R -- a. Total integration of spectrum - 448 
divisions (29 or 30 protons) 
b. No absorption between 6.7-8 8 (compound 
is non-aromatic or is fully substituted ' 
aromatic) 
c. No absorption between 3 .4-3. 8 6 ( -OCH3 
groups absent) 
d. No absorption between 4 and 6 8 (ally1ic 
or vinyl~c proton absent) 
e. Sharp, o
2
o exchangeable, peak at 4 6 (-OH 
or -NH group present) 
f. Signals for C-CH3 or N-OI3 not clear 
(possibly absent) 
......... ~ 
1 
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In order to more definitively characterize hopeanine, 
its molecular weight and molecular formula were determined. 
The clas-sical method of determining molecular weights and 
elemental composition of- a compound could not be used. 
Data obtained by low resolution and high resolution elec-
tron impact ionization (EI) mass spectrometry (MS) and 
chemical ionization (Cl) MS and 13c mtR was therefore 
used. 
Low resolution US (Fig. 15) showed apparent molecular 
i _on peaks at 314 and .315 m/ e. This sugg-ested that the 
molecular we-ight of hopeanine was either 314 or 315. Based 
on the intensities of the M+l peaks, various molecular 
formulas for the two possible molecular weights could be 
suggested. High resolution -Ms (Figs. 1-9, 20) gave a more 
precise measurement of the mass of the ions 314 and 315. 
The mass of the ion .314 was determined to be 314.220947 
and that of 315 ion was found to be 315.227051. The pos-
sible molecular formulas for these weights are 
-Analysis of the low resolution MS suggested at this 
stage that the M~W- of hopeanine was 314, since the inten-
sity of the m/e peak for 314 was too high to be considered 
as M-1 peak of the 315 ion. On this basis the molecular 
formula C H N 0 was tentatively assigned to hopeanine. 
lEi 30 2 4 
This seemed to agree with the 29-30 protons suggested to 
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Computer print-out of the wide band 
1
H 
decoupled 13c ID1R spectrum of bopeanine 
89 
r 
i 
-y 
l 
90 
be presen-t in the compound by the PMR spectrum (see above). 
As it turned out, this .assumption was erroneous. 
The wide-band 1n decoupled C-13 mtR spectrum of 
the compound (Figs. 17, 18), besides being extremely help-
ful in giving information regarding some structural features 
of hopeanine also showed that there were at least 19 carbon 
atoms, with at least 28 hydrogens attached to these carbons, 
thus indicating that the molecular formula assumed above 
was in error. 
The chemical ionization MS of hopeanine- was able 
to resolve this problem. This spectrum showed that the 
M+l ion was at 316. Therefore the unequivocal M.W. of 
hopeanine was 315 and not 314 as previously assumed. The 
non-nitrogen containing molecular formulas among the list 
shown above can be rejected. From the number of carbons 
observed in C-13 NMR and the fac-t that the formulas 
C16H31N2o4 and c 21n 31N2o4 represent even electron ions 
(51), the molecular formula c19H29N30 can be unambiguously 
assigned to bopeanine. 
A great deal of structural information could be 
obtained from the wide-band 1n decoupled C-13 NMR spec-
truro of hopeanine (Fig. 17). As indicated above, the 
presenc-e of at least 19 carbon atoms was shown by this 
spectrum. Figure 18 represents a copy of the computer 
1 
print-out of the anal~r sis of the wide band II decoupled 
spectrum of bopeanine, indicating the line number (peak#), 
frequency (H..z) ,_ parts per mi 11 ion ( o). area of peak and 
! , 
intensity of each peak. It should be pointed out that 
the analysis by the computer takes into considera.tion 
every line (peak) observed, thus accounting for the 
listed 27 lines. 
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The single frequency proton off-resonance decoupled 
C-13 ~'MR allows assigrunents of peaks to various carbon 
environments such as non-protonated carbon and carbons 
attached to one, two, or three hydrogens (-Cll. -CH2 • -CH3 ). 
These environments are observed_ as s ·inglets. doublets, 
triplets or quartets, respectively. Twelve ~riplets (-CH2 ), 
four doublets ( -CH) and three singlets (non-protonat-ed car-
bans) were observed in the spectrum of hopeanine. Absence 
of quartets indicated absence of -CH3 group. This is in 
agreement with the analysis of PMR which had indicated that 
C-methyl or N-~ethyl were probably absent (p. 83). 
Further attempts were made to assign various car-
bon environments to the observed C-13 NMR peaks (signals) 
using literature reported o values (46, 52). The signals 
appearing at 169.276 and 150.811 (singlets) were of special 
interest. These, according to literature (46, 52), may 
reflect unsaturated environments and location of such an 
environment in an unknown compound is significant. The 
UV and IR had indicated such an environment and its charac-
terization would help in elucidating the structure of 
hopeanine. Tables XII and XIII list assignments of environ-
ments most likely to be associated with these two carbons. 
r 
I 
~ 
f 
t 
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Table XII: Some environments of carbons with a value 
nf be~ween 149-150 6 
Stru~ture Refe-rence 
150.6 46 
149.6 46 
149.7 54 
0 };:-NH . HU=o· 152.8 46 
~ CH(CH~) / 2 ~ 151.0 53 R N_/ CH.t 
H \\ 
0 
a 152.0 52 O CH 3 
149.5 55 
92 
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Table XII: (continued) 
Reference 
149.9 56 
H 
OH CH3 
CH 20H-
150.6, 161.0 56 
j 
. I 
I 
I 
1 
Tahle XIII: Some environments of carbons with a val·ue 
between 168 - 172 6 
94 
Reference 
167.9 46 
168.9 46 
0 
II CH-.r<;-N(Me)2 169.6 46 
• CH-·C-CI 
3 II 169.9 46 
0 
0 
II 
CH3-C-OEt 170.3 46 
• 0 
II 169.8 46 . 
CH 3-c-o-< it 
0 
II 1/ 
46 CH 3-C-O- 168.9 
. ' 
0 
II 
OZN N-H-G-CH 3 169.2 46 ~ 
Table XII1: (continued) 95 
Structure 6 Reference 
-
~ -\ 
I 
tf\0--... \ 1;-
I 168.5. 171.8 57 
i 
' 
·\'\ 
Q 168.2 46 
9 0 ~0 
' 
0 . 
I 
I 
I 
' 
168.5 59 
I 
! 
168.9 58 
----· · 
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It is evident that one can conceive of a variety 
of environments for the carbons whos-e c values are 150.811 
and 169.276. However, many of the environments could be 
eliminated based on the evidence of functional groups 
in the IR spectrum of hopeanine. -For example, the o value 
of 169.276 cannot be due to carbonyl group as no carbonyl 
absorption is e-vident in t ·he IR spectrum. Thus one can 
limit the possible environments of the carbons to the 
following. 
' l 
, 
0 
By similar arguments one can conceive of the fol-
lowing environments for the carbons with o valu-e of 15.0. 811. 
R 
c:>-1 X'/ 
For a molecular formula c19H29N30, the corresponding 
parent hydrocarbon must have- a composition c22H32 · The 
corresponding saturated hydrocarbon can then be represented 
by a composition c 22H46 . Thus in hopeanine there is a 
. 
f 
' 
' 
J 
J 
I 
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deficiency of 14 hydrogens or an equivalent of 7 unsatura-
tion units (comprising rings and/or double bonds). 
13c m1R indicated that two of the unsaturations 
could be accounted for by C=N or C=C bonds. The remaining 
five unsaturation units may then be accounted for as repre-
senting five rings. 
The shift values for the a carbon, in ethanol, -
1-propanol, 2-propanol and 2-methyl-2-propanol are 57.3, 
63.9, 63.7 and 68.7 6, respectively (46). The wide band 
1 H decoupled spectrum of hopeanine shows a peak at 56.793 
6. If this ~as attributed to a primary alcoholic group, 
then the carbinol carbon would be expected to appear as 
a triplet in the single frequency, off resonance decoupled 
spectrum. However, this peak was seen as a doublet. This 
rules out the possibility that the peak a.t 56. 7·93 o r.epre-
sents a -CH2 attached to an -OH. Further, the a carbon 
~n secondary and tertiary alcohols such as 2-propanol and 
2-methyl-2-propanol, appears at much higher o value than 
that observed. Thus the oxyge n in the formula c19n29N3o 
is not part of a carbonyl or a hydroxy functional group. 
Hence the exchangeable hydrogen seen in the P~!R s pectrum 
of hopeanine is ·most likely to be part of an -NII group. 
So f ·ar the molecular weight and formula of hopeanine 
had been determined with cer.t~inty. The spectral analyses 
also gave some indications as to a few functional groups 
present in the compound. Detailed structural determinations 
and assignment of final composite structure could be made 
, . 
J 
j 
j 
; 
j 
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by the analysis of the high resolution mass .spectrum, (Fig. 19) 
especially the available extensive computer pLint-out. 
A copy of selected mje peaks and their computer analysis 
i.s shown in Fig. 20. The observed fragment ions were (Table XIV) 
assigned most probable structures and finally these struc-
tures were fit into a whole structure for hopean·ine. 
a) Fragments at m/e 92 (I) and mfe 120 (II) were 
even electron ions. The most suitable struc-
ture for these ions were 
•+ 
I 
b) Ion fr:agments at mje 148 (III) was an even 
electron ion, while the ion at m/e 146 was 
an odd electron ion. The probable structures 
for these ions are 
til Hlt 
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Table X.IV. Irnnortant odd electron ions in the rnas:s 
spectrum of hopeanine 
mje Probable Composition 
273 c16a23N30 
190 C11H14N20 
146 C9H10N2 
Important even electron ions in the mass 
spectrum of hopea.nine 
286 Cl7H24N30 
272 Cl6H22N30 
257 C16H21N20 
231 Cl4Hl9N20 
189 C11Hl3N20 
174 Cl1Hl2NO 
161 C10H13N2 
148 c9a10NO 
120 C8HlON 
92 c6H6N 
103 
104 
·c) The fragments at m/e 161 and mfe 174 were 
even electron ions and the likely structures 
for these fragments are 
d) The Iragment at mfe 189 (VII) was an even 
electron ion while the ion at mfe 190 was 
an odd electron ion with a composition 
CllH14N20. 
VII 
.._., 
.... 
e) The fragments at mfe 231 and mfe 257 were 
even electron ions and the probable struc-
tures of these fragments are 
•• 
f) The fragment .ion at mje 272 was an even 
electron ion while th.e ion at mfe 273 was 
an odd electron ion with a composition 
Cl6H23N30 
105 
-
.. ---
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g) The fragments at m/e 286 and m/e 314 were 
even electron ions and the· probable structures 
of these ions are 
h) The fragment ion at mje 315 was the molecular 
ion with a composition c19H29N3o 
•+ 
A composite of these fragments and the· most suitable struc-
tures assigned to these ion fragments is shown in Fig. 21. 
The high resolution mass spectrum of the alkaloid 
is characterized by the presence a strong hl-1 peak. Cyclic 
amines, aldehydes, secondary or primary alcohols usually 
show a significant M-1 peak in their mass spectrum. It is 
most likely that in the pres-ent case t ·he M-1 peak repre-
sents the loss of proton from the -NH group. The fragmenta-
tion then proceeds in two competing directions, as shown in 
Figure 21. The loss of an m/e 42 ,. c3H6 fragment gives 
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Mass spectral fragmentation pathways of 
hopeanine 
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mfe 272, c16n22N3o. the strongest peak after the base 
peak mfe 57. The fragment ion 272 is an even electron ion 
and yield-s the even electron ion m/e 189. c11H13N2o by loss 
of mfe 83, c5H9N. The neutral fragment c5H9N might prob-
ably represent a methylene pyrrolidine or piperidine 
group. In the other possible pathway ~ the m/e 314 ion 
could fra~ent by the loss of m/e 57 ion to yield the 
even electron ion, c16H21N2o of m/e 257. The latter could 
cleave by the loss of c2H2 fragment to yield the even elec-
tron ion c14H19N20, mj-e 231. This latter fragment ion could 
also be produced by the direct loss of c5H9N fragment from 
mje 314. Fragment ion m/e 231 can lose either m/3 42 to 
yield the ion 189 as above or lose another c5H9N fragment 
to form the even electron ion mfe 148, c9H10N. The ion 
mfe 189 can also fragment in two ways: a) Loss of mfe 
28 (CO) would give mje 161, c10H13N2 or the loss of C2H3N 
(acetonitrile) would yield the above ion mje 148·. The 13c 
satellites of all the fragments mentioned have been identi-
fied in the high resolution mass spectrum. However further 
confirmation of the above sequence of fragmentation re-
actions can be done only with the aid of the necessary 
. 
metastable ions. 
A number of other fragment ions can be explained 
on the basis of a retro-Diels-Alder reaction mechanism (51). 
These are -- mje 174, c11n12NO from mje 257, C16H2lN20 by 
the loss of c5H9N or fragmentation of mje 161, c10n13N2 and 
mfe 148, c9u10NO to smaller fragment ions, . e.g. mfe 14·6, 120, 
--- ---. 
106, 94, 92, and mje 78. These fragments represent a 
variety of pyridine derivatives. 
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A structure as shown below can now be assigned to 
hopeanine which helps explain the various spectral data 
discussed in these pages. 
The presence of the a-substitued pyrrolidine ring 
as shown in the above structure was suggested from the 
analysis of the low resolution hlS (Fig. 16). The two ions 
at m/e 69 (47%) and mje 70 (32%) were quite prominent. 
These are characteristic of a-methyl pyrrolidines. The 
·presence of the postulated neutral fragment C~H9N (Fig. 21) • 0 
also supports this analysis. A second support to the pres-
ence of a-substituted pyrrolidine was obtained from the 
C--13 NMR (Fig. 16). s ·ignals in the region of 47-49 o were 
observed. Shift values for carbons a and S to the nitrogen 
in a pyrrolidine ring and those for carbons a, a and y 
to the nltro.gen in a p·iperidine ring have· ·been reported 
110 
in the literature (46) as follows: 
The structure of hopeanine proposed above, also 
seems to be consistent with biosyn.thetic considerations 
of the alkaloids of the· Solanaceae family. The trepan€ 
group of alkaloids, found in many solanaceous plants, 
contain piperidine and pyrrolidine residues. 
pyrrolidine-------~----------piperidine 
The pyrrolidine residue has been demonstrated to 
be derived from ornithine and the piperidine residua from 
lysine (60). The proposed hopeanine structure also incor-
porates pyrrolidine and piperidine units, although in a 
unique structure. It would be reasonable to assume that 
......_. --
,, 
~--
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hopeanine also would be biosynthcsized from ornithine and 
lysine. At least the proposed structure does not exclude 
the possibility. Although various other st ructur·es could 
be written for hopeanine which would agree with some 
data, the one proposed above was the on.ly one to agree with 
all the considerations. 
In addition to determination of biosynthetic path-
ways of hopeanine,additional future research directions 
would be as follows: 
The unambiguous final proof of the structure 
of hopeanine remains to be elucidated. This 
can be obtained by unequivocal chemical syn.-
thesis. Other supportive evidence to the pro-
posed structure could not be obtained due to 
paucity of material and lack of equipment. 
High resolution MS in the metastable mode and 
establishing the mother-daughter relationships 
would be helpful (51). The C-13 ID1R of ·the 
acetate would also offer additional support. An 
attempt to acetylate 8 mg of hopeanine did in-
dicate that reaction had occurred (tested by 
TLC); however the purified sample was too small 
to give a good, interpretable spectrum. X-ray 
crystallography could also provide valuable 
information. I~wever, attempts at growing good 
crystals of hopeanine have not been successful 
to d
4
ate; the compound is sensitive to .air, light 
and moisture. 
......., 
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